PSQ (PSQH) 10-Q 12 Nov 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2024	Nov. 08, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-40457
Entity Registrant Name	PSQ Holdings, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	86-2062844
Entity Address, Address Line One	250 S. Australian Avenue
Entity Address, Address Line Two	Suite 1300
Entity Address, City or Town	West Palm Beach
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33401
City Area Code	(877)
Local Phone Number	776-2402
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Central Index Key	0001847064
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Class A common stock, par value $0.0001 per share
Document Information [Line Items]
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	PSQH
Security Exchange Name	NYSE
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
Trading Symbol	PSQH.WS
Security Exchange Name	NYSE
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		31,548,544
Class C Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		3,213,678

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 4,709,237	$ 16,446,030
Restricted cash	966,529	0
Accounts receivable, net	622,419	204,879
Loans held for investment, net of allowance for credit losses of $558,612 as of September 30, 2024	3,567,832	0
Interest Receivable	304,599	0
Inventory	1,500,715	1,439,182
Prepaid expenses and other current assets	4,288,699	3,084,576
Total current assets	15,960,030	21,174,667
Loans held for investment, net of allowance for credit losses of $106,530 as of September 30, 2024, non-current	680,400	0
Property and equipment, net	299,768	127,139
Intangible assets, net	15,948,378	3,557,029
Goodwill	10,930,978	0
Operating lease, right-of-use assets	350,782	324,238
Deposits	75,579	63,546
Total assets	44,245,915	25,246,619
Current liabilities
Revolving line of credit	3,108,871	0
Accounts payable	3,664,680	1,828,508
Accrued expenses	906,745	1,641,553
Deferred revenue	571,363	225,148
Operating lease liabilities, current portion	167,749	310,911
Total current liabilities	8,419,408	4,006,120
Warrant liabilities	2,632,500	10,130,000
Earn-out liabilities	150,000	660,000
Operating lease liabilities	191,502	16,457
Total liabilities	39,842,910	14,812,577
Commitments and contingencies (Note 16)
Stockholders’ equity
Preferred stock, $0.0001 par value; 50,000,000 authorized shares; no shares issued and outstanding as of September 30, 2024 and December 31, 2023	0	0
Additional paid in capital	103,562,504	72,644,419
Accumulated deficit	(99,162,765)	(62,213,139)
Total stockholders’ equity	4,403,005	10,434,042
Total liabilities and stockholders’ equity	44,245,915	25,246,619
Related Party
Current liabilities
Convertible promissory notes	20,000,000	0
Nonrelated Party
Current liabilities
Convertible promissory notes	8,449,500	0
Class A Common Stock
Stockholders’ equity
Common stock	2,945	2,441
Class C Common Stock
Stockholders’ equity
Common stock	$ 321	$ 321

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Net of allowance for credit losses, current	$ 558,612
Net of allowance for credit losses, non-current	$ 106,530
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, authorized shares (in shares)	50,000,000	50,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	500,000,000	500,000,000
Common stock, issued (in shares)	29,451,684	24,410,075
Common stock, outstanding (in shares)	29,451,684	24,410,075
Class C Common Stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	40,000,000	40,000,000
Common stock, issued (in shares)	3,213,678	3,213,678
Common stock, outstanding (in shares)	3,213,678	3,213,678

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenues, net	$ 6,540,112	$ 2,030,900	$ 15,991,229	$ 2,938,641
Costs and expenses:
Cost of revenue (exclusive of depreciation and amortization expense shown below)	609,270	569,502	1,738,729	1,189,440
Cost of goods sold (exclusive of depreciation and amortization expense shown below)	1,771,109	903,672	4,601,360	903,672
Transaction costs incurred in connection with the Business Combination	0	3,309,597	0	7,048,177
General and administrative	12,295,934	4,311,199	33,552,605	7,448,015
Sales and marketing	4,607,708	3,670,309	14,380,677	6,739,149
Research and development	973,544	1,486,069	3,147,296	3,310,943
Depreciation and amortization	975,090	759,745	2,202,561	2,004,319
Total costs and expenses	21,232,655	15,010,093	59,623,228	28,643,715
Operating loss	(14,692,543)	(12,979,193)	(43,631,999)	(25,705,074)
Other income (expense):
Other (expense) income, net	(45,683)	119,957	110,295	173,644
Change in fair value of convertible promissory notes	0	0	0	(14,571,109)
Change in fair value of earn-out liabilities	170,000	450,000	510,000	450,000
Change in fair value of warrant liabilities	2,175,000	(7,783,000)	7,497,500	(7,783,000)
Interest expense, net	(756,760)	(46,690)	(1,434,241)	(210,545)
Loss before income taxes	(13,149,986)	(20,238,926)	(36,948,445)	(47,646,084)
Income tax benefit (expense)	12,437	262	(1,181)	(1,527)
Net loss	$ (13,137,549)	$ (20,238,664)	$ (36,949,626)	$ (47,647,611)
Net loss per common share, basic (in dollars per share)	$ (0.41)	$ (0.77)	$ (1.21)	$ (2.38)
Net loss per common share, diluted (in dollars per share)	$ (0.41)	$ (0.77)	$ (1.21)	$ (2.38)
Weighted average shares outstanding, basic (in shares)	31,758,032	26,265,627	30,526,102	20,058,726
Weighted-average shares outstanding, diluted (in shares)	31,758,032	26,265,627	30,526,102	20,058,726

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)	Total	Previously Reported	Revision of Prior Period, Adjustment	Preferred Stock	Preferred Stock Previously Reported	Preferred Stock Revision of Prior Period, Adjustment	Common Stock Class A Common Stock	Common Stock Class A Common Stock Previously Reported	Common Stock Class A Common Stock Revision of Prior Period, Adjustment	Common Stock Class C Common Stock	Common Stock Class C Common Stock Previously Reported	Common Stock Class C Common Stock Revision of Prior Period, Adjustment	Additional Paid-In Capital	Additional Paid-In Capital Previously Reported	Additional Paid-In Capital Revision of Prior Period, Adjustment	Subscription Receivable	Subscription Receivable Previously Reported	Subscription Receivable Revision of Prior Period, Adjustment	Accumulated Deficit	Accumulated Deficit Previously Reported	Accumulated Deficit Revision of Prior Period, Adjustment
Beginning balance (in shares) at Dec. 31, 2022				0	0	0	11,806,007	771,155	11,034,852	3,213,678	0	3,213,678
Beginning balance at Dec. 31, 2022	$ 3,401,413	$ 3,401,413	$ 0	$ 0	$ 0	$ 0	$ 1,181	$ 771	$ 410	$ 321	$ 0	$ 321	$ 12,383,475	$ 12,384,206	$ (731)	$ (99,612)	$ (99,612)	$ 0	$ (8,883,952)	$ (8,883,952)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of notes to common stock	2,050,000
Issuance of common stock for cash (in shares)							1,447,523
Issuance of common stock for cash	2,500,124						$ 145						2,499,979
Receipt of subscription (receivable) payable	100,012															100,012
Issuance of common stock for asset acquisition (in shares)							1,071,229
Issuance of common stock for asset acquisition	1,334,858						$ 107						1,334,751
Net loss	(6,687,640)																		(6,687,640)
Ending balance at Mar. 31, 2023	648,767			$ 0			$ 1,433			$ 321			16,218,205			400			(15,571,592)
Ending balance (in shares) at Mar. 31, 2023				0			14,324,759			3,213,678
Beginning balance (in shares) at Dec. 31, 2022				0	0	0	11,806,007	771,155	11,034,852	3,213,678	0	3,213,678
Beginning balance at Dec. 31, 2022	3,401,413	3,401,413	0	$ 0	$ 0	$ 0	$ 1,181	$ 771	$ 410	$ 321	$ 0	$ 321	12,383,475	12,384,206	(731)	(99,612)	(99,612)	0	(8,883,952)	(8,883,952)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(47,647,611)
Ending balance at Sep. 30, 2023	11,505,088			$ 0			$ 2,434			$ 321			68,033,896			0			(56,531,563)
Ending balance (in shares) at Sep. 30, 2023				0			24,340,075			3,213,678
Beginning balance (in shares) at Dec. 31, 2022				0	0	0	11,806,007	771,155	11,034,852	3,213,678	0	3,213,678
Beginning balance at Dec. 31, 2022	3,401,413	$ 3,401,413	$ 0	$ 0	$ 0	$ 0	$ 1,181	$ 771	$ 410	$ 321	$ 0	$ 321	12,383,475	$ 12,384,206	$ (731)	(99,612)	$ (99,612)	$ 0	(8,883,952)	$ (8,883,952)	$ 0
Ending balance at Dec. 31, 2023	10,434,042			$ 0			$ 2,441			$ 321			72,644,419			0			(62,213,139)
Ending balance (in shares) at Dec. 31, 2023				0			24,410,075			3,213,678
Beginning balance (in shares) at Mar. 31, 2023				0			14,324,759			3,213,678
Beginning balance at Mar. 31, 2023	648,767			$ 0			$ 1,433			$ 321			16,218,205			400			(15,571,592)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of notes to common stock	20,450,000
Receipt of subscription (receivable) payable	(400)															(400)
Net loss	(20,721,307)																		(20,721,307)
Ending balance at Jun. 30, 2023	(20,072,940)			$ 0			$ 1,433			$ 321			16,218,205			0			(36,292,899)
Ending balance (in shares) at Jun. 30, 2023				0			14,324,759			3,213,678
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of notes to common stock (in shares)							3,984,388
Conversion of notes to common stock	37,294,023						$ 397						37,293,626
Issuance of common stock for Credova Merger (in shares)							7,735,151
Issuance of common stock for Credova Merger	12,426,780						$ 774						12,426,006
Forfeiture of shares (in shares)							(1,704,223)
Forfeiture of shares	0						$ (170)						170
Share-based compensation	2,095,889												2,095,889
Net loss	(20,238,664)																		(20,238,664)
Ending balance at Sep. 30, 2023	11,505,088			$ 0			$ 2,434			$ 321			68,033,896			0			(56,531,563)
Ending balance (in shares) at Sep. 30, 2023				0			24,340,075			3,213,678
Beginning balance (in shares) at Dec. 31, 2023				0			24,410,075			3,213,678
Beginning balance at Dec. 31, 2023	10,434,042			$ 0			$ 2,441			$ 321			72,644,419			0			(62,213,139)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for Credova Merger (in shares)							2,920,993
Issuance of common stock for Credova Merger	14,137,606						$ 292						14,137,314
Issuance of shares for consulting arrangement (in shares)							183,349
Issuance of shares for consulting arrangement	887,409						$ 18						887,391
Issuance of shares for fully vested restricted stock units (in shares)							663,500
Issuance of shares for fully vested restricted stock units	0						$ 66						(66)
Share-based compensation	5,410,894												5,410,894
Net loss	(12,576,831)																		(12,576,831)
Ending balance at Mar. 31, 2024	18,293,120			$ 0			$ 2,817			$ 321			93,079,952			0			(74,789,970)
Ending balance (in shares) at Mar. 31, 2024				0			28,177,917			3,213,678
Beginning balance (in shares) at Dec. 31, 2023				0			24,410,075			3,213,678
Beginning balance at Dec. 31, 2023	10,434,042			$ 0			$ 2,441			$ 321			72,644,419			0			(62,213,139)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(36,949,626)
Ending balance at Sep. 30, 2024	4,403,005			$ 0			$ 2,945			$ 321			103,562,504			0			(99,162,765)
Ending balance (in shares) at Sep. 30, 2024				0			29,451,684			3,213,678
Beginning balance (in shares) at Mar. 31, 2024				0			28,177,917			3,213,678
Beginning balance at Mar. 31, 2024	18,293,120			$ 0			$ 2,817			$ 321			93,079,952			0			(74,789,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	5,171,761												5,171,761
Net loss	(11,235,246)																		(11,235,246)
Ending balance at Jun. 30, 2024	12,229,635			$ 0			$ 2,817			$ 321			98,251,713			0			(86,025,216)
Ending balance (in shares) at Jun. 30, 2024				0			28,177,917			3,213,678
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares for fully vested restricted stock units (in shares)							1,273,767
Issuance of shares for fully vested restricted stock units	(485,904)						$ 128						(486,032)
Share-based compensation	5,796,823												5,796,823
Net loss	(13,137,549)																		(13,137,549)
Ending balance at Sep. 30, 2024	$ 4,403,005			$ 0			$ 2,945			$ 321			$ 103,562,504			$ 0			$ (99,162,765)
Ending balance (in shares) at Sep. 30, 2024				0			29,451,684			3,213,678

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash Flows from Operating Activities
Net loss	$ (36,949,626)	$ (47,647,611)
Adjustment to reconcile net loss to cash used in operating activities:
Change in fair value of convertible promissory notes	0	14,571,109
Change in fair value of warrant liabilities	(7,497,500)	7,783,000
Change in fair value of earn-out liabilities	(510,000)	(450,000)
Share-based compensation	16,855,006	2,095,889
Realized gain on short term investment	0	(173,644)
Amortization of step-up in loans held for investment	501,112	0
Provision for credit losses on loans held for investment	549,985	0
Origination of loans and leases for resale	(17,315,173)	0
Proceeds from sale of loans and leases for resale	19,689,911	0
Gain on sale of loans and leases	(2,374,738)	0
Depreciation and amortization	2,202,561	2,004,319
Non-cash operating lease expense	314,577	129,216
Interest expense	0	58,455
Changes in operating assets and liabilities:
Accounts receivable	(722,139)	(67,604)
Prepaid expenses and other current assets	65,810	(681,471)
Inventory	(61,533)	(1,476,085)
Deposits	(12,033)	(70,202)
Accounts payable	(1,577,703)	2,597,462
Accrued expenses	(322,928)	2,845,964
Deferred revenue	346,215	199,304
Operating lease payments	(309,238)	(130,429)
Net cash used in operating activities	(27,127,434)	(18,412,328)
Cash flows from Investing Activities
Software development costs	(2,818,954)	(1,840,066)
Principal paydowns on loans held for investment	8,897,046	0
Disbursements for loans held for investment	(7,168,697)	0
Acquisition of businesses, net of cash acquired	141,215	0
Purchase of short-term investments	0	(10,049,870)
Proceeds from the sale of short-term investments	0	10,223,514
Purchase of intangible assets and trademarks	0	(86,600)
Purchases of property and equipment	0	(113,065)
Net cash used in investing activities	(949,390)	(1,866,087)
Cash flows from Financing Activities
Proceeds from convertible note payable, related party (Note 12)	20,000,000	0
Proceeds from convertible note payable	0	22,500,000
Proceeds from reverse recapitalization	0	18,104,194
Proceeds from issuance of common stock under stock plans, net of shares withheld for employee taxes	(485,904)	0
Proceeds from the issuance of common stock	0	2,600,125
Repayments on revolving line of credit	(2,207,536)	0
Repayment of subscription payable	0	(400)
Net cash provided by financing activities	17,306,560	43,203,919
Net (decrease) increase in cash and cash equivalents	(10,770,264)	22,925,504
Cash, cash equivalents and restricted cash beginning of period	16,446,030	2,330,405
Cash, cash equivalents and restricted cash end of the period	5,675,766	25,255,909
Cash and cash equivalents	4,709,237	25,255,909
Restricted cash	966,529	0
Total cash, cash equivalents and restricted cash, end of the period	5,675,766	25,255,909
Supplemental Non-Cash Investing and Financing Activity
Promissory notes, inclusive of accrued interest, converted to equity	0	37,294,023
Initial recognition of earn-out liability	0	2,400,000
Acquisition of warrant liability	0	8,816,500
Prepaid expenses assumed in connection with Business Combination	0	2,570,594
Liabilities assumed in connection with Business Combination	0	92,929
Liabilities paid through the trust	0	1,778,672
Accrued variable compensation settled with RSU grants	411,878	0
Shares issued in connection with Credova Merger	14,137,606	0
Note Exchange in connection with Credova Merger	8,449,500	0
Stock for stock transfer	$ 0	$ 1,334,858

Organization and Business Opera

Organization and Business Operations	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Business Operations	Organization and Business Operations PSQ Holdings, Inc. (collectively “PublicSquare”, “PSQ”, “PSQH” or the “Company”) is a commerce and payments ecosystem, valuing life, family, and liberty. PublicSquare operates under three segments: Marketplace, Financial Technology, and Brands (“Marketplace”, “Financial Technology”, and “Brands”). The primary mission of the Marketplace segment is to help consumers “shop their values” and put purpose behind their purchases. PublicSquare leverages data and insights from the Marketplace to assess its customers’ needs and provide wholly-owned quality financial products and brands. PublicSquare’s Financial Technology segment comprises of Credova, a consumer financing and PublicSquare Payments, a payments company. PublicSquare’s Brands segment comprises EveryLife, a premium direct-to-consumer (“D2C”) life-affirming baby products company, and PSQLink, LLC (“PSQLink”), a digital marketing and customer relationship management (“CRM”) platform. EveryLife Asset Acquisition In February 2023, the Company acquired the assets of EveryLife, Inc. (“EveryLife”). On July 13, 2023, the Company launched the brand and began generating revenue from sales of diapers and wipes from this operation. See Note 5 for further information. Merger Agreement On July 19, 2023, in accordance with the plan of arrangement to reorganize PSQ Holdings. Inc, the Company finalized a business combination (the “Business Combination”) with Colombier Acquisition Corp. (“Colombier”). On closing, the common shares of PSQ Holdings Inc. were listed on the New York Stock Exchange and commenced trading under the symbol “NYSE:PSQH”. See Note 4 for further information. Credova Merger On March 13, 2024, the Company entered into an agreement and plan of merger (the “Credova Merger Agreement”) with Cello Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary (“Merger Sub”) of the Company, Credova Holdings, Inc., a Delaware corporation (“Credova”), and Samuel L. Paul, in the capacity as the Seller Representative in accordance with the terms of the Credova Merger Agreement (“Credova Merger”). See Note 5 for further information. The Company’s operations are comprised of three operating segments which are Marketplace, Brands and Financial Technology a summary of which is below: Marketplace The PSQ platform (the “Platform”) can be accessed through two primary means: • Mobile application - Our mobile app is available for both iOS and Android-based devices. • Web - Users can access our full platform at PublicSquare.com. Brands Our brand revenues have been derived primarily from our sale of products. EveryLife is a direct-to-consumer baby care company with a mission to provide premium products to every miraculous life. EveryLife is committed to its core values, ensuring product quality, and demonstrating generosity by donating diapers and wipes to moms in need. This commitment has quickly set EveryLife apart, elevating both its brand and products. Since its launch in July 2023, EveryLife has been delivering high-performing and price-accessible products that align with the values of our consumers. Additionally, the Company has built out PSQLink, which is generating revenues through Business-to-Business (“B2B”) sales by providing its customers with a digital marketing and CRM platform. Financial Technology Credova assists consumers, lenders, and retailers in offering point-of-sale financing products. Credova has developed and maintains an internet-based proprietary retail finance platform and related application programming interfaces (“APIs”) through which Credova, certain Federal Deposit Insurance Corporation (“FDIC”) and National Credit Union Administration (“NCUA”) insured financial institutions, other financial institutions authorized by Credova (each a “Financing Partner”), and merchants can dynamically offer certain financing products. Credova’s offerings fall into four main categories: (i) Merchant-originated products; (ii) Bank Partner-originated closed-end installment loans; (iii) Credova-originated loan products; and (iv) Zero-interest installment products (“Pay-in-4”). In addition to Credova, the Company is developing a payments stack, PSQPayments LLC (“PublicSquare Payments”), which will consist of a framework of technological components and services that the Company’s customers can utilize to manage their payment processes, which falls under the Financial Technology segment. As of September 30, 2024, there has been no revenue generated from PublicSquare Payments.

Liquidity

Liquidity	9 Months Ended
	Sep. 30, 2024
Liquidity [Abstract]
Liquidity	Liquidity Historically, the Company’s primary sources of liquidity have been funds from financing activities. The Company reported net losses of $36.9 million and $47.6 million for the nine months ended September 30, 2024 and 2023, respectively, and had negative cash flows from operations of $27.1 million and $18.4 million for the nine months ended September 30, 2024 and 2023, respectively. As of September 30, 2024 and December 31, 2023, the Company had aggregate unrestricted cash and cash equivalents, of $4.7 million and $16.4 million and net working capital of $7.5 million and $17.2 million, respectively. On October 24, 2024, the Company closed a private investment in public equity transaction (“PIPE”) pursuant to a Securities Purchase Agreement (“PIPE Purchase Agreement”) dated October 22, 2024, for the purchase of $5.35 million of Class A common stock at $2.70 per share with three investors: (i) an affiliate of a PSQH board member, (ii), a party related to a PSQH board member and executive officer, and (ii) an unaffiliated accredited investor (the “Purchasers”) (see Note 17 for additional information). The Company’s Board of Directors and executive team have outlined a plan to improve the Company’s cash position which involves a variety of cash management initiatives. These initiatives include reduction and reallocation of resources to more profitable segments of the business and reducing corporate operating expenses. The reduction of resources, which included a staff reduction of 35% along with terminating or reducing contractor and consulting agreements was performed in October 2024 and is expected to result in annualized cash savings of approximately $11.0 million. Additionally, the plan considers further options such as completing a capital raise, entering into a revolving line of credit agreement, and refining inventory purchase timing which will reduce excess stock levels. The Company believes that, as a result of these initiatives, along with its existing cash and cash equivalents and the cash flow from the Brands and Financial Technology segments, the Company will be able to fund operations and capital needs for the next year from the date these condensed consolidated financial statements were available to be issued. The Company’s future capital requirements will depend on many factors including the Company’s revenue growth rate, the timing and extent of spending to support further sales and marketing and research and development efforts. In order to finance these opportunities, the Company may need to raise additional financing. While there can be no assurances, the Company may need to pursue issuances of additional equity raises and debt rounds of financing. If additional financing is required from outside sources, the Company may not be able to raise it on terms acceptable to the Company or at all. If the Company is unable to raise additional capital when desired, the Company’s business, results of operations and financial condition would be materially and adversely affected.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) for interim financial information. Accordingly, certain information and footnote disclosures normally included in consolidated financial statements in accordance with U.S. GAAP have been omitted. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. All significant intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet at December 31, 2023 has been derived from the audited consolidated financial statements at that date, but does not include all disclosures, including notes, required by U.S. GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for its year ended December 31, 2023. Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts and disclosures of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Estimates are adjusted to reflect actual experience when necessary. Such estimates include, but are not limited to, revenue recognition, allowance for credit losses, fair values of net assets acquired, intangible assets, inventory valuation, estimates related to useful lives of long-lived assets, estimation of contingencies, recoverability of deferred tax assets, the incremental borrowing rate applied to lease accounting, valuation of earn out liabilities and warrant liabilities, and estimation of income taxes. These estimates, judgments, and assumptions are reviewed periodically, and the impact of any revisions are reflected in the condensed consolidated financial statements in the period in which such revisions are made. Actual results could differ materially from those estimates, judgments, or assumptions, and such differences could be material to the Company’s consolidated financial position and results of operations. Earnings (Loss) Per Share The Company computes basic loss per share (“EPS”) by dividing loss available to common stockholders by the weighted average number of common shares outstanding for the reporting period. All securities that meet the definition of a participating security, irrespective of whether the securities are convertible, nonconvertible, or potential common stock securities, shall be included in the computation of basic EPS using the two-class method. However, when the different classes of units have identical rights and privileges except voting rights, whereby they share equally in dividends and residual net assets on a per unit basis, the classes can be combined and presented as one class for EPS purposes. As such, the Company has combined the Class A and Class C Common stock for purposes of the EPS calculation. Diluted loss per share is calculated by dividing net loss by the weighted average number of common shares and dilutive common stock equivalents outstanding. During the periods when there are anti-dilutive, common stock equivalents, these are not considered in the computation. As of September 30, 2024, the Company’s restricted stock units (“RSUs”) and Warrants were not considered in the computation as they are anti-dilutive. As of September 30, 2024, there were no anti-dilutive shares or common stock equivalents outstanding. Revenue Recognition [1] Marketplace Revenues E-commerce revenues The Platform features a single cart shopping experience where consumers can purchase a variety of products from multiple vendors in one transaction. The Company is not the seller of record in these transactions. The commissions revenue earned from these arrangements is recognized on a net basis, which equates to the commission and processing fees earned in exchange for the seller marketplace services. The commission and processing fees are recognized net of estimated refunds when the buyer and seller confirm the corresponding transaction. The Company does not take title to inventory sold or assume risk of loss at any point in time during the transaction and is authorized to collect consideration from the buyer and remit net consideration to the seller to facilitate the processing of the confirmed purchase transaction. The Company currently records processing fees from its merchant service providers as a component of Cost of revenues on the condensed consolidated statement of operations. Advertising services The Company enters into advertising subscription arrangements with its customers. Revenue is recognized over-time as the ads are displayed over the subscription period. The Company is providing a service and the service is being consumed by the customer simultaneously over the period of service. In general, the Company reports advertising revenue on a gross basis, since the Company controls the advertising inventory before it is transferred to our customers. Our control is evidenced by our sole ability to monetize the advertising inventory before it is transferred to customers. The Company also sells push notifications and email blasts and recognizes revenue at a point in time when delivered. Push notifications and email blasts are considered delivered when an ad is displayed to users. When a customer enters into an advertising subscription arrangement that includes push notifications and/or email blasts, the Company allocates a portion of the total consideration to the push notification and email blast performance obligations based on the residual approach. In June 2024, the Company launched its cost per mille (“CPM”) advertising model. The advertising revenue related to CPM is recognized based on the number of impressions received from advertising on websites or mobile device applications, or as the advertiser’s previously agreed-upon performance criteria are satisfied. [2] Brand Revenues Product sales The Company generates revenue through the sale of diapers and wipes to consumers by way of the Company’s Platform and EveryLife’s website. Additionally, EveryLife provides discounted products to non-profit organizations and other strategic partners through bulk sales at discounted prices. The Company considers customer orders to be the contracts with the customer. There is a single performance obligation, which is the Company’s promise to transfer its product to customers based on specific payment and shipping terms in the arrangement. The entire transaction price is allocated to this single performance obligation. Product revenue is recognized when a customer obtains control of the product, which occurs at shipment. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. The Company evaluated principal versus agent considerations to determine whether it is appropriate to record third-party logistics provider fees paid as an expense. These fees are recorded as shipping and handling expenses within cost of goods sold and are not recorded as a reduction of revenue because the Company owns and controls all the goods before they are transferred to the customer. The Company can, at any time, direct the third-party logistics provider to return the Company’s inventories to any location specified by the Company. It is the Company’s responsibility to process any returns made by customers directly to logistic providers and the Company retains the back-end inventory risk. Further, the Company is subject to credit risk (i.e., credit card chargebacks), establishes prices of its products, fulfills the goods to the customer and can limit quantities or stop selling the goods at any time. Product Returns Consistent with industry practice, the Company generally offers customers a limited right of return for products purchased. The Company reviews its receivables quarterly and records a reserve, if necessary. As of September 30, 2024 and December 31, 2023, the Company had $0 and $15,000, respectively, recorded as an allowance for sales returns. B2B Sales PSQLink generates recurring software as a service (“SaaS”) revenues through B2B sales by providing its customers with a digital marketing and CRM platform. [3] Financial Technology Revenues Financing Revenues The Company principally generates financing revenue from four activities: revenue from sale of loan and lease contracts, revenue from interest earned on loans, revenue from retailer discounts, and origination fees paid by lending institutions (direct revenue) earned in connection with providing financing on consumer goods. Revenue from leases is recognized over time when the Company satisfies a performance obligation based on the agreed upon financing terms. Revenue from the Company’s sales of loans and leases is recognized at a point in time when the Company satisfies a performance obligation by transferring control of the loans to a third party. Interest on loans is calculated by the simple-interest method on daily balances of the principal amount outstanding. Revenue from retailer discounts is recognized at a point in time when the Company satisfies performance obligations by purchasing the contract from the merchant in connection with a merchant-originated consumer financing product. Origination fees from lenders are recognized at the time of loan origination. Cash and Cash Equivalents The Company considers all highly liquid investments with a maturity of 90 days or less at the time of purchase to be cash equivalents. The carrying values of cash and cash equivalents approximate their fair values due to the short-term nature of these instruments. The Company maintains cash accounts with financial institutions. At times, balances in these accounts may exceed federally insured limits. No losses have been incurred to date on any deposits. Restricted cash The Company has two Deposit Account Control Agreements (“DACA”) with lenders. With these agreements, the Company assigned the rights to a collateral account to the lenders. The DACA accounts are utilized to collect the consumer payments on loans and leases. Funds are then distributed in accordance with the loan security agreement. Funds cover payments for servicing, interest on revolving loans, and paying down revolving loans . Loans held for Investment, net Loans are unsecured and are stated at the amount of unpaid principal. Interest on loans is calculated by the simple-interest method on daily balances of the principal amount outstanding. Accrued interest on loans is discontinued when management believes that, after considering collection efforts and economic and business conditions, the collection of interest is doubtful. The Company’s policy is to stop accruing interest when the loan becomes 120 days’ delinquent. All interest accrued but not collected for loans that are placed on nonaccrual status or subsequently charged-off is reversed against interest income which is included in revenues, net on the condensed consolidated statements of operations. Income is subsequently recognized on the cash basis until, in management’s judgment, the borrower’s ability to make periodic and future principal and interest payments are reasonably assured, in which case the loan is returned to accrual status. The Company classifies its loans as either current or past due. Amounts are considered past due if a scheduled payment is not paid on its due date. The Company does not modify the terms of its existing loans with customers. Allowance for credit losses Loans held for investment The Company identifies its portfolio segments and measures the allowance for credit losses based on similar economic risk characteristics. The allowance for credit losses for each portfolio is determined based on the Company’s current estimate of expected credit losses over the remaining contractual term, adjusted for expected prepayments when appropriate, and incorporates evaluations of known and inherent risks in our portfolio, historical credit losses, consumer payment trends, estimates of recoveries, current economic conditions, and reasonable and supportable forecasts. Loans that do not share risk characteristics are evaluated on an individual basis. Loans evaluated individually are not included in the collective evaluation. Business Combinations The Company evaluates whether acquired net assets should be accounted for as a business combination or an asset acquisition by first applying a screen test to determine whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If so, the transaction is accounted for as an asset acquisition. If not, the Company applies its judgment to determine whether the acquired net assets meets the definition of a business by considering if the set includes an acquired input, process, and the ability to create outputs. The Company accounts for business combinations using the acquisition method when it has obtained control. The Company measures goodwill as the fair value of the consideration transferred including the fair value of any non-controlling interest recognized, less the net recognized amount of the identifiable assets acquired and liabilities assumed, all measured at their fair value as of the acquisition date. Transaction costs, other than those associated with the issuance of debt or equity securities, that the Company incurs in connection with a business combination are expensed as incurred. Any contingent consideration (“Earn-out liabilities”) is measured at fair value at the acquisition date. For contingent consideration that does not meet all the criteria for equity classification, such contingent consideration is required to be recorded at their initial fair value at the acquisition date, and on each balance sheet date thereafter. Changes in the estimated fair value of liability-classified contingent consideration are recognized on the condensed consolidated statements of operations in the period of change. When the initial accounting for a business combination has not been finalized by the end of the reporting period in which the transaction occurs, the Company reports provisional amounts. Provisional amounts are adjusted during the measurement period, which does not exceed one year from the acquisition date. These adjustments, or recognition of additional assets or liabilities, reflect new information obtained about facts and circumstances that existed at the acquisition date that, if known, would have affected the amounts recognized at that date. Inventory Inventory consists of finished goods and is stated at lower of cost or net realizable value. Cost is measured by using an adjusted standard cost method which approximates FIFO (first in, first out). The net realizable value of the Company’s inventory is estimated based on current and forecasted demand, and market conditions. The allowance for excess and obsolete inventory requires management to make assumptions and to apply judgment regarding a number of factors, including estimates applying past and projected sales performance to current inventory levels. As of September 30, 2024 and December 31, 2023, no reserve for inventory has been recorded. Goodwill and acquired intangible assets Goodwill in the Company’s condensed consolidated financial statements resulted from the Credova Merger, while the acquired intangible assets recorded in the Company’s condensed consolidated financial statements resulted from both the EveryLife asset acquisition and the Credova Merger. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed. Goodwill is not amortized as it is estimated to have an indefinite life. As such, goodwill is subject to an annual impairment test. The Company allocates goodwill to reporting units based on the expected benefit from the business combination. Reporting units are evaluated when changes in the Company’s operating structure occur, and if necessary, goodwill is reassigned using a relative fair value allocation approach. Accounting Standards Codification (“ASC”) 350, Intangibles—Goodwill and Other ("ASC 350") requires goodwill to be tested for impairment at least annually or more frequently if events or changes in circumstances indicate that goodwill may be impaired. The Company elects to perform an annual impairment test of goodwill as of December 31 of each year. The accounting guidance gives the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The qualitative assessment considers events and circumstances that might indicate that a reporting unit’s fair value is less than its carrying amount. If it is determined, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative test is performed. Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Acquired identifiable finite-lived intangible assets are amortized on a straight-line basis over the estimated useful life of the respective asset. Each period the Company evaluates the estimated remaining useful lives of its intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization. Acquired indefinite-lived intangible assets are not amortized but are tested for impairment at least annually or more frequently if events or changes in circumstances indicate that the intangible asset may be impaired. Capitalized Software The Company capitalizes costs related to the development of its internal software and certain projects for internal use in accordance with ASC 350-40, Internal-Use Software ("ASC 350-40"). The Company capitalizes costs to develop its mobile application and website when preliminary development efforts are successfully completed, management has authorized and committed project funding, it is probable that the project will be completed, and the software will be used as intended. Costs incurred during the preliminary planning and evaluation stage of the project and during the post implementation operational stage, including maintenance, are expensed as incurred. Costs incurred for enhancements that are expected to result in additional functionality are capitalized and expensed over the estimated useful life of the upgrades on a per project basis. Amortization is computed on an individual product basis over the estimated economic life of the product using the straight-line method. Software development costs expensed and not capitalized, which are included in research and development expense in the accompanying condensed consolidated statements of operations, were approximately $0.08 million and $0.08 million for the three months ended September 30, 2024 and 2023, respectively, and $0.2 million and $1.0 million for the nine months ended September 30, 2024, and 2023, respectively. Impairment of Long-Lived Assets The Company reviews long-lived assets, including intangible assets, capitalized software and lease assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured first by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are impaired, an impairment loss would be recognized based on the excess of the carrying amount of the asset above the fair value of the asset. No impairment of the Company’s long-lived assets were recorded during the nine months ended September 30, 2024 and 2023. Convertible Promissory Notes The Company may enter into convertible promissory notes, some of which contain predominantly fixed rate conversion features, whereby the holder may convert the outstanding principal and accrued interest into common shares at a fixed discount to the market price of the common stock at the time of conversion. In this case, the convertible promissory notes represent a financial instrument other than an outstanding share that embodies a conditional obligation that the issuer must or may settle by issuing a variable number of its equity shares. The Company records the convertible note liability at its fixed monetary amount by measuring and recording a premium, as applicable, on the convertible notes date with a charge to expense in accordance with ASC 480, Distinguishing Liabilities from Equity ("ASC 480"). Warrant Liabilities The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 815-40, Derivatives and Hedging (“ASC 815-40”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company accounts for the Public Warrants (as defined in Note 11) and the Private Placement Warrants (collectively, with the Public Warrants, the “Warrants”) in accordance with the guidance contained in ASC 815-40 under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each reporting period until exercised, and any change in fair value is recognized in the condensed consolidated statements of operations. The Warrants for periods where no observable traded price was available are valued using a Black-Scholes option pricing model. For the Public Warrants, quoted market price will be used as the fair value as of each relevant date. Leases The Company determines if an arrangement is a lease at inception. For leases where the Company is the lessee, right-of-use (“ROU”) assets represent the Company’s right to use the underlying asset for the term of the lease and the lease liabilities represent an obligation to make lease payments arising from the lease. The Company’s lease agreement contains rent escalation provisions, which are considered in determining the ROU assets and lease liabilities. The Company begins recognizing rent expense when the lessor makes the underlying asset available for use by the Company. Lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments over the lease term. Lease renewal periods are considered on a lease-by-lease basis in determining the lease term. The interest rate the Company uses to determine the present value of future lease payments is the Company’s incremental borrowing rate because the rate implicit in the Company’s leases is not readily determinable. The incremental borrowing rate is a hypothetical rate for collateralized borrowings in economic environments where the leased asset is located based on credit rating factors. The ROU asset is determined based on the lease liability initially established and adjusted for any prepaid lease payments and any lease incentives received. The lease term to calculate the ROU asset and related lease liability includes options to extend or terminate the lease when it is reasonably certain that the Company will exercise the option. Certain leases contain variable costs, such as common area maintenance, real estate taxes or other costs. Variable lease costs are expensed as incurred on the condensed consolidated statements of operations. Operating leases are included in the ROU assets and lease liabilities on the condensed consolidated balance sheets. The Company has no finance leases. Share Based Compensation The Company recognizes an expense for share-based compensation awards based on the estimated fair value of the award on the date of grant. For certain awards, the Company has determined that the service inception date precedes the grant date as (a) the awards were authorized prior to establishing an accounting grant date, (b) the recipients began providing services prior to the grant date, and (c) there are performance conditions that, if not met by the accounting grant date, will result in the forfeiture of the awards. As the service inception date precedes the accounting grant date, the Company recognizes share-based compensation expense over the requisite service period based on the fair value on the award grant date. Fair Value of Financial Instruments Fair value is the price that would be received to sell an asset, or the amount paid to transfer a liability in an orderly transaction between market participants at the measurement date. There is a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The Company classifies fair value balances based on the observability of those inputs. The three levels of the fair value hierarchy are as follows: Level 1 - Inputs based on unadjusted quoted market prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets or quoted prices for identical or similar instruments in markets that are not active or for which all significant inputs are observable or can be corroborated by observable market data. Level 3 - Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are both unobservable for the asset and liability in the market and significant to the overall fair value measurement. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The Company establishes the fair value of its assets and liabilities using the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and establishes a fair value hierarchy based on the inputs used to measure fair value. The recorded amounts of certain financial instruments, including money markets classified as cash equivalents, accounts receivable, loans held for investment at fixed interest rates, accounts payable, accrued expenses, debt at fixed interest rates, and other liabilities approximate fair value due to their relatively short maturities. The Company’s policy is to record transfers between levels, if any, as of the beginning of the fiscal year. For the three and nine months ended September 30, 2024 and 2023 no transfers between levels have been recognized. Segment Reporting Operating segments are defined as components of an entity for which separate discrete financial information is available that is evaluated regularly by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company has determined that the Company has three reportable segments comprised of Marketplace, Brands and Financial Technology. Concentration of Risks Financial instruments that potentially subject the Company to a significant concentration of credit risk consist primarily of cash and cash equivalents, and accounts receivable. Cash balances may exceed the FDIC insurance limit of $250,000. The Company has not experienced any losses in such accounts. For the three months ended September 30, 2024, one customer accounted for 10.6% of the Company’s revenue. For the three months ended September 30, 2023, no customer accounted for 10% or more of the Company’s revenue. For the nine months ended September 30, 2024 and 2023, no customer accounted for 10% or more of the Company’s revenue. As of September 30, 2024, one customer accounted for 18.5% of the Company’s accounts receivable. As of December 31, 2023, no customer accounted for 10% or more of the Company’s accounts receivable. Recent Accounting Pronouncements In March 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") No. 2024-01, Compensation—Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards (“ASU 2024-01”), which intends to improve clarity and comparability without changing the existing guidance. ASU 2024-01 provides an illustrative example intended to demonstrate how entities that account for profits interest and similar awards would determine whether a profits interest award should be accounted for in accordance with ASC 718, Compensation—Stock Compensation ("ASC 718"). Entities can apply the guidance either retrospectively to all prior periods presented in the financial statements or prospectively to profits interest and similar awards granted or modified on or after the date of adoption. ASU 2024-01 is effective for annual periods beginning after December 15, 2024, and interim periods within those annual periods. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is currently evaluating the potential impact of adopting ASU 2024-01 on its condensed consolidated financial statements. In November 2024, the FASB issued ASU No. 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03") , which is intended to improve the disclosures of expenses by providing more detailed information about the types of expenses in commonly presented expense captions. The ASU requires entities to disclose the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization included in each relevant expense caption; as well as a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. The amendment also requires disclosure of the total amount of selling expense and, in annual reporting periods, an entity’s definition of selling expenses. The ASU is effective for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027; however early adoption is permitted. The ASU can be applied either prospectively or retrospectively. The Company is currently evaluating the potential impact of adopting ASU 2024-01 on its condensed consolidated financial statements. The Company has assessed the adoption impacts of recently issued accounting standards by the FASB on the Company’s condensed consolidated financial statements as well as material updates to previous assessments, if any, to the Company’s annual audited consolidated financial statements and notes thereto included in our Form 10-K for the year ended December 31, 2023.

Recapitalization

Recapitalization	9 Months Ended
	Sep. 30, 2024
Recapitalization [Abstract]
Recapitalization	Recapitalization On July 19, 2023, the Company consummated the Business Combination, pursuant to the terms of the Merger Agreement dated February 27, 2023 with Colombier. At Closing, pursuant to the terms of the Merger Agreement and after giving effect to the redemptions of Class A Common Stock, par value $0.0001 per share, of Colombier (the “Colombier Class A Common Stock”) by public stockholders of Colombier: • all options, convertible notes, warrants and other rights to subscribe for or purchase any capital stock of PSQ or securities convertible into or exchangeable for, or that otherwise conferred on the holder any right to acquire, any capital stock of PSQ which remained outstanding and had not been exercised or did not convert automatically into shares of PSQ Common Stock (as defined below) prior to the effective time of the Merger (the “Effective Time”) were canceled without consideration; • each share of PSQ Common Stock, par value $0.001 per share (“PSQ Common Stock”), including shares of PSQ Common Stock issued upon conversion of outstanding convertible notes of PSQ that automatically converted into shares of PSQ Common Stock immediately prior to the completion of the Merger, in each case other than shares of PSQ Common Stock held by the CEO, was automatically converted into the right to receive 19.476836 shares of Class A Common Stock, par value $0.0001 per share, of the Company (“Class A Common Stock”); and • each share of PSQ Common Stock held by the Chief Executive Officer (“CEO”) was automatically converted into the right to receive 19.476836 shares of Class C Common Stock, par value $0.0001 per share, of the Company (“Class C Common Stock” and, together with Class A Common Stock, “Company Common Stock”). In addition to the right of holders’ of PSQ Common Stock immediately prior to the Effective Time (the “PSQ Stockholders”) to receive Class A Common Stock or Class C Common Stock, as applicable, in the Merger, PSQ Stockholders and certain executive officers, employees and service providers of PSQ (the “Deemed Equity Holders” and, together with the PSQ Stockholders, the “Participating Equity Holders”) will be entitled to receive up to 3,000,000 shares of Class A Common Stock (the “Earnout Shares”) in the event certain trading price-based metrics are satisfied during the five (5)-year period commencing on the date of the Closing and ending on the fifth anniversary thereof (the “Earnout Period”), or, if earlier, upon the occurrence of a change of control transaction (as defined in the Merger Agreement) during the Earnout Period with an implied per share price that exceeds the relevant trading price-based metrics. Specifically, Earnout Shares will be earned if one or more of the three (3) triggering events described below occurs: • in the event that, and upon the date during the Earnout Period on which, the volume-weighted average trading price of Class A Common Stock quoted on the New York Stock Exchange (“NYSE”) (or such other exchange on which the shares of Class A Common Stock are then listed) for any twenty (20) trading days within any thirty (30) consecutive trading day period (the “Earnout Trading Price”) is greater than or equal to $12.50 , the Participating Equity Holders will be entitled to receive an aggregate of 1,000,000 Earnout Shares; • in the event that, and upon the date during the Earnout Period on which, the Earnout Trading Price is greater than or equal to $15.00, the Participating Equity Holders will be entitled to receive an aggregate of 1,000,000 additional Earnout Shares; and • in the event that, and upon the date during the Earnout Period on which, the Earnout Trading Price is greater than or equal to $17.50, the Participating Equity Holders will be entitled to receive an aggregate of 1,000,000 additional Earnout Shares. Each share of the Company’s Class C Common Stock entitles its holder, initially the CEO, to a number of votes per share (rounded up to the nearest whole number) equal to (a) the aggregate number of outstanding shares of Class A Common Stock entitled to vote on the applicable matter as of the applicable record date plus 100, divided by (b) the aggregate number of outstanding shares of Class C Common Stock (the “Per Share Class C Voting Power”). As of the Closing Date, as a result of his ownership of 100% of the outstanding Class C Common Stock, the CEO has approximately 52.62% of the voting power of the Company, and the result of most matters to be voted upon by the Company’s stockholders will be controlled by the CEO, who can base his vote upon his best judgment and his fiduciary duties to PSQ stockholders. Each share of Class C Common Stock held by the CEO may be converted by the CEO at any time into one (1) share of Class A Common Stock. PSQ has been determined to be the accounting acquirer based on evaluation of the following facts and circumstances: • PSQ’s existing stockholders will have the ability to control decisions regarding election and removal of directors and officers of the Company; • PSQ is the larger entity in terms of substantive operations and employee base; • PSQ will comprise the ongoing operations of the Company; and • PSQ’s existing senior management will be the senior management of the Company. Accordingly, the Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this method of accounting, although Colombier acquired all the outstanding equity interests of PSQ in the Business Combination, Colombier was treated as the “acquired” company and PSQ was treated as the accounting acquirer for financial statement reporting purposes. Accordingly, the Business Combination was treated as the equivalent of PSQ issuing stock for the net assets of Colombier, accompanied by a recapitalization. The net assets of Colombier were stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination will be those of PSQ. Transaction Proceeds Upon closing of the Business Combination, the Company received gross proceeds of $34.9 million from the Business Combination, offset by total transaction costs of $16.8 million. The following table reconciles the elements of the Business Combination to the condensed consolidated statements of cash flows and the condensed consolidated statement of changes in stockholders’ equity: Cash-trust and cash, net of redemptions $ 34,938,880 Less: transaction costs and advisory fees, paid (16,834,686) Net proceeds from the Business Combination 18,104,194 Less: public and private placement warrant liabilities (8,816,500) Less: earn-out liabilities (2,400,000) Add: amounts paid in advance 2,570,919 Add: Transaction costs in accounts payable and accrued expenses 2,967,393 Reverse recapitalization, net $ 12,426,006 The number of shares of Common Stock issued immediately following the consummation of the Business Combination were: Colombier Class A common stock, outstanding prior to the Business Combination 17,250,000 Less: Redemption of Colombier Class A common stock (13,827,349) Class A common stock of Colombier 3,422,651 Colombier Class B common stock, outstanding prior to the Business Combination 4,312,500 Business Combination shares 7,735,151 PSQ Shares 21,522,825 Common Stock immediately after the Business Combination 29,257,976 The number of PSQ shares was determined as follows: PSQ Shares PSQ Class A Common Stock 940,044 18,309,147 Class C Common Stock 165,000 3,213,678 Total 1,105,044 21,522,825 Public and private placement warrants The Public Warrants issued in Colombier’s Initial Public Offering (“IPO”) and 5,700,000 warrants issued in connection with private placement at the time of Colombier’s IPO (the “Private Placement Warrants”) remained outstanding and became warrants for the Company (see Note 11). Redemption Prior to the closing of the Business Combination, certain Colombier public shareholders exercised their right to redeem certain of their outstanding shares for cash, resulting in the redemption of 13,827,349 shares of Colombier Class A common stock for an aggregate payment of $141,151,432.

Acquisitions

Acquisitions	9 Months Ended
	Sep. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Acquisitions	Acquisitions Credova On March 13, 2024, the Company entered into the Credova Merger Agreement. Pursuant to the Credova Merger Agreement, on March 13, 2024, Merger Sub merged with and into Credova. In connection with the Merger, each share of Credova’s equity was converted into the right to receive newly-issued shares of PSQ Class A common stock, and was delivered to the Credova stockholders at the closing (“Credova Stockholders”). Credova Merger Consideration As consideration for the Credova Merger, Credova Stockholders received 2,920,993 newly-issued shares of Class A Common Stock (the “Consideration Shares”). A number of Consideration Shares equal to ten percent (10%) of the Consideration Shares (the “Escrow Shares”) was placed in an escrow account for indemnity claims made under the Credova Merger Agreement. Assuming they are not subject to indemnity claims, the Escrow Shares remaining in escrow upon the 12-month anniversary of the closing will be released and distributed pro rata to the former Credova Stockholders. The acquisition of Credova was accounted for as a business combination using the acquisition method pursuant to ASC 805, Business Combinations ("ASC 805"). As the acquirer for accounting purposes, the Company estimated the purchase price, assets acquired and liabilities assumed as of the acquisition date, with the excess of the purchase price over the fair value of net assets acquired recognized as goodwill. The purchase price allocation as of the acquisition date is presented as follows: March 13, Purchase consideration: Common Stock, at fair value $ 14,137,606 Assumption of notes payable 8,449,500 Cash paid 1,587,184 Total purchase consideration $ 24,174,290 Purchase price allocation: Cash $ 1,728,400 Loans held for investment 7,027,678 Fixed assets 243,879 Intangible assets 11,720,000 Prepaid expenses 1,269,933 Goodwill 10,930,978 Operating lease right of use asset 341,121 Accounts payable and other current liabilities (3,430,171) Lease liability (341,121) Revolving line of credit (5,316,407) Fair value of net assets acquired $ 24,174,290 The excess of purchase consideration over the fair value of net tangible and identifiable intangible assets acquired was recorded as goodwill and is primarily attributed to the synergies expected from expanded market opportunities when integrating the acquired developed technologies with the Company’s offerings as well as acquiring an assembled workforce. The goodwill balance is not deductible for income tax purposes. Acquisition-related costs of $2.3 million associated with the Credova Merger were included in general and administrative expenses in the condensed consolidated statement of operations for the three and nine months ended September 30, 2024. Since the acquisition date, $3.2 million of revenue and $1.1 million of net loss have been included in the condensed consolidated statement of operations for the three months ended September 30, 2024 and $6.6 million of revenue and $2.5 million of net loss have been included in the condensed consolidated statement of operations for the nine months ended September 30, 2024. The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition (in years): Fair value Useful life Trademarks and Tradenames $ 1,700,000 5 Internally developed software 3,600,000 3 Merchant relationships 5,900,000 5 State operating licenses 520,000 Indefinite Total intangible assets $ 11,720,000 The following unaudited supplemental pro forma combined financial information presents the Company’s combined results of operations for the three and nine months ended September 30, 2024 and 2023 as if the Credova Merger had occurred on January 1, 2023. The pro forma financial information is presented for comparative purposes only and is not necessarily indicative of the Company’s operating results that may have occurred had the Credova Merger been completed on January 1, 2023. In addition, the unaudited pro forma financial information does not give effect to any anticipated cost savings, operating efficiencies or other synergies that may be associated with the merger, or any estimated costs that have been or will be incurred by the Company to integrate the assets and operations of Credova. Three months Nine months Revenue $ 6,540,112 $ 18,904,794 Net loss $ (13,137,549) $ (35,558,372) Three months Nine months Revenue $ 5,600,958 $ 13,895,120 Net loss $ (20,987,828) $ (52,109,581) The unaudited pro forma financial information reflects pro forma adjustments to present the combined pro forma results of operations as if the acquisition had occurred on January 1, 2023 to give effect to certain events the Company believes to be directly attributable to the acquisition. These pro forma adjustments primarily include: (i) the elimination of Credova historical depreciation and amortization expense and the recognition of new depreciation and amortization expense; (ii) an adjustment to present acquisition-related transaction costs and other one-time costs directly attributable to the acquisition as if they were incurred in the earliest period presented; and (iii) the related income tax effects of the adjustments noted above, as applicable. EveryLife In February 2023, the Company acquired the assets of EveryLife, by way of a stock for stock exchange with a company wholly owned by an insider. Pursuant to that agreement, the Company acquired a brand name in exchange for 1,071,229 shares of the Company’s common stock. Through the stock for stock exchange agreement, the Company acquired EveryLife’s marketing related intangibles which consist of a brand name. On July 13, 2023, the Company launched the brand and began generating revenue from sales of diapers and wipes from this operation. This acquisition was accounted for as an asset purchase. The cost of a group of assets acquired in an asset acquisition shall be allocated to the individual assets acquired or liabilities assumed based on their relative fair values and shall not give rise to goodwill. The following table presents the acquisition date fair value of the asset acquired: Assets acquired: Balance - January 1, 2023 $ — Issuance of common stock at fair value 1,334,850 Legal costs capitalized 42,611 Balance - December 31, 2023 $ 1,377,461

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, Net	Goodwill and Intangible Assets, Net Goodwill as of September 30, 2024 was $10.9 million, which resulted from the Credova Merger (See Note 5) and is included in the Financial Technology segment. The following table summarizes intangible assets, net: Useful September 30, December 31, Capitalized software development costs 1-5 years $ 7,748,105 $ 5,011,519 Trademark and tradenames 5 years 1,700,000 — Internally developed software 3 years 3,600,000 — Merchant relationships 5 years 5,900,000 — State operating licenses Indefinite 520,000 — Purchased technology 1-15 years 247,489 247,489 Brand name 10 years 1,377,461 1,377,461 Total intangible assets 21,093,055 6,636,469 Less: Accumulated amortization (5,144,677) (3,079,440) Total intangible assets, net $ 15,948,378 $ 3,557,029 Amortization expenses were approximately $0.9 million and $0.7 million for the three months ended September 30, 2024 and 2023, respectively, and $2.1 million and $2.0 million for the nine months ended September 30, 2024 and 2023, respectively. As of September 30, 2024, estimated future amortization expense is expected as follows: Remainder of 2024 $ 1,168,960 2025 3,793,004 2026 3,793,004 2027 2,791,739 2028 2,894,054 Thereafter 1,507,617 $ 15,948,378

Loans Held for Investment, Net

Loans Held for Investment, Net	9 Months Ended
	Sep. 30, 2024
Receivables [Abstract]
Loans Held for Investment, Net	Loans Held for Investment, Net The Company classifies its loans as either current or past due. The following reflects the credit quality of the Company’s loans held for investment, as delinquency status has been identified as the primary credit quality indicator, based on the recorded amount of the receivable in delinquent status as of September 30, 2024: Past Due Current 30-59 Days 60-89 days > 90 days Total Loans held for investment $ 4,770,333 $ 66,839 $ 46,173 $ 30,029 $ 4,913,374 Allowance for credit losses (665,142) Loans held for investment, net $ 4,248,232 These loans have a variety of lending terms as well as original maturities ranging from six weeks to thirty-six months, with the large majority of the Company’s loans having a term of approximately two years. The average remaining life of the Company’s loans was approximately 12 months as of September 30, 2024. Given that the Company’s loan portfolio focuses on unsecured installment loans, the Company evaluates the portfolio as a single homogeneous loan portfolio and performs further analysis by product type as needed. The Company closely monitors credit quality for its loans held for investment to manage and evaluate exposure to credit risk. Credit risk management begins with initial underwriting, where a consumer is assessed based on the Company’s underwriting and credit policy. This includes Know Your Customer (“KYC”) identification, traditional credit scoring models, and various Fair Credit Reporting Act (“FCRA”) permissible consumer credit and risk data. Credit quality is monitored subsequent to underwriting based on performance metrics that include, but are not limited to, delinquency and default metrics. The Company uses software that monitors credit quality of the respective portfolio and performs analysis on credit data. The changes in allowance for credit losses on loans held for investment as of September 30, 2024 is as follows: Balance at January 1, 2024 $ — Balance acquired from Credova Merger 1,130,515 Charge-offs (1,015,358) Provision for credit losses 549,985 Balance at September 30, 2024 $ 665,142

Revolving Line of Credit

Revolving Line of Credit	9 Months Ended
	Sep. 30, 2024
Line of Credit Facility [Abstract]
Revolving Line of Credit	Revolving Line of Credit The Company assumed a $10.0 million revolving loan with a finance company through the Credova Merger (Note 5) which bears interest at a rate of 15% and requires minimum monthly interest payments. The funding termination date is June 30, 2024. The borrowing base is based upon a percentage of eligible receivables which are valued as the outstanding principal amount, less adjustments for loans held for investment that are more than thirty-one days but no more than sixty days past due. For calculating the borrowing base, receivables more than sixty days past due are excluded. The total amount that can be borrowed under the loan is reduced to the amount of the borrowing base if that amount is lower. On July 1, 2024 the Company entered into Amendment No. 5 to the Amended and Restated Loan and Security Agreement. The amendment extended the funding period for an additional 12 months beginning July 1, 2024. The line of credit will bear interest at an annual rate of 14.5% with minimum interest requirement. The borrowing base is set at 89% of the unpaid principal balance of pledge receivables that are no more than sixty days past due. The amendment contains customary covenants, trigger events, representations and warranties. Certain assets at Credova are assigned as collateral. The revolving line of credit maturity date is subsequent to the revolving period, which is the earlier of: (a) nine (9) months following the funding termination date (June 30, 2025) and (b) the remittance date on which the aggregate outstanding advances are $1.0 million or below. Monthly remittance remains in effect with a borrowing base calculation. During the amortization period, the Company will repay the aggregate outstanding advances until such aggregate outstanding advances do not exceed the borrowing base, and then 100% of the remaining collections until the aggregate outstanding advances have been reduced to zero. As of September 30, 2024, the outstanding advances under this revolving loan totaled $3.1 million. Promissory Note Exchange Prior to the execution of the Credova Merger Agreement, Credova, PSQ and certain holders of outstanding subordinated notes (“Subdebt Notes”) issued by Credova (the “Participating Noteholders”) entered into a Note Exchange Agreement (the “Note Exchange Agreement”) pursuant to which, immediately prior to the Closing, the Participating Noteholders delivered their Subdebt Notes of Credova for cancellation, in exchange for newly-issued replacement notes issued by PSQ, convertible into shares of Class A Common Stock (the “Replacement Notes”). The Replacement Notes have 9.75% simple interest per annum and 10-year maturity dates. Pursuant to the terms of the Replacement Notes, at any time after the Closing, Participating Noteholders may elect to convert their Replacement Notes into a number of shares of Class A Common Stock equal to the quotient obtained by dividing (x) the outstanding principal amount of the Replacement Note to be converted plus accrued and unpaid interest by (y) 4.63641, subject to adjustment for stock splits and other similar transactions (the “Conversion Price”). At any time, the Company may call the Replacement Notes for a cash amount equal to accrued interest plus (i) between the Closing and the first anniversary of the Closing, 120% of the then outstanding principal amount, (ii) between the first anniversary and the second anniversary of the Closing, 105% of the then outstanding principal amount and (iii) after the second anniversary of the Closing, the then outstanding principal amount of the Replacement Note. Further, the Replacement Notes permit the Company, in its discretion, to require conversion of the Replacement Notes into shares of Class A Common Stock if the daily volume-weighted average trading price of the Company Class A Common Stock exceeds 140% of the Conversion Price on each of at least ten consecutive trading days during the twenty trading day period prior to notice of such required conversion. The Company determined the embedded derivatives did not require bifurcation. Credova Subdebt Notes not exchanged for Replacement Notes at Closing were canceled following payment in full in cash. As of September 30, 2024, the convertible promissory notes payable was $8.4 million. Convertible Promissory Notes – Related Party In March 2024, the Company entered into a note purchase agreement for a 9.75% private placement convertible note for $10.0 million invested by a board member and his affiliates. Terms for the note were priced based on notes exchanged as part of the Credova Merger described above. In August 2024, the Company entered into an agreement for a $10.0 million convertible note in a private placement with a board member and affiliates. The note has identical terms to the notes offered in March 2024 (see Note 12). Convertible Promissory Notes The Company had issued convertible promissory notes (the “Note” or “Notes”) in the total amount of $22.5 million that accrued interest at the rate of 5% per annum until converted or paid in full upon maturity being December 31, 2024. As described in Note 1, on July 19, 2023, the Company consummated the Business Combination and became a publicly-traded company at which time the balance under each Note converted automatically into shares of PSQ Common Stock at a conversion price per share based upon an implied $100 million fully diluted pre-money valuation, excluding the Notes. The Notes are required to be recorded at their initial fair value on the date of issuance under ASC 480-10-25-14, and each balance sheet date thereafter. Changes in the estimated fair value of the Notes are recognized as non-cash gains or losses in the condensed consolidated statements of operations. The change in the fair value of the Notes measured with Level 3 inputs through September 30, 2023 are summarized as follows: Convertible Fair value as of January 1, 2023 $ — Principal balance of convertible notes issued 2,050,000 Change in valuation inputs or other assumptions 1,147,905 Fair value as of March 31, 2023 3,197,905 Principal balance of convertible notes issued 20,450,000 Change in valuation inputs or other assumptions 13,423,204 Fair value as of June 30, 2023 37,071,109 Conversion of convertible notes (37,071,109) Fair value as of September 30, 2023 $ — The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates: Exercise Price $ — Risk-Free Rate 4.1 % Maturity (in years) 1.8 Volatility 75.0 %

Convertible Promissory Notes

Convertible Promissory Notes	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Convertible Promissory Notes	Revolving Line of Credit The Company assumed a $10.0 million revolving loan with a finance company through the Credova Merger (Note 5) which bears interest at a rate of 15% and requires minimum monthly interest payments. The funding termination date is June 30, 2024. The borrowing base is based upon a percentage of eligible receivables which are valued as the outstanding principal amount, less adjustments for loans held for investment that are more than thirty-one days but no more than sixty days past due. For calculating the borrowing base, receivables more than sixty days past due are excluded. The total amount that can be borrowed under the loan is reduced to the amount of the borrowing base if that amount is lower. On July 1, 2024 the Company entered into Amendment No. 5 to the Amended and Restated Loan and Security Agreement. The amendment extended the funding period for an additional 12 months beginning July 1, 2024. The line of credit will bear interest at an annual rate of 14.5% with minimum interest requirement. The borrowing base is set at 89% of the unpaid principal balance of pledge receivables that are no more than sixty days past due. The amendment contains customary covenants, trigger events, representations and warranties. Certain assets at Credova are assigned as collateral. The revolving line of credit maturity date is subsequent to the revolving period, which is the earlier of: (a) nine (9) months following the funding termination date (June 30, 2025) and (b) the remittance date on which the aggregate outstanding advances are $1.0 million or below. Monthly remittance remains in effect with a borrowing base calculation. During the amortization period, the Company will repay the aggregate outstanding advances until such aggregate outstanding advances do not exceed the borrowing base, and then 100% of the remaining collections until the aggregate outstanding advances have been reduced to zero. As of September 30, 2024, the outstanding advances under this revolving loan totaled $3.1 million. Promissory Note Exchange Prior to the execution of the Credova Merger Agreement, Credova, PSQ and certain holders of outstanding subordinated notes (“Subdebt Notes”) issued by Credova (the “Participating Noteholders”) entered into a Note Exchange Agreement (the “Note Exchange Agreement”) pursuant to which, immediately prior to the Closing, the Participating Noteholders delivered their Subdebt Notes of Credova for cancellation, in exchange for newly-issued replacement notes issued by PSQ, convertible into shares of Class A Common Stock (the “Replacement Notes”). The Replacement Notes have 9.75% simple interest per annum and 10-year maturity dates. Pursuant to the terms of the Replacement Notes, at any time after the Closing, Participating Noteholders may elect to convert their Replacement Notes into a number of shares of Class A Common Stock equal to the quotient obtained by dividing (x) the outstanding principal amount of the Replacement Note to be converted plus accrued and unpaid interest by (y) 4.63641, subject to adjustment for stock splits and other similar transactions (the “Conversion Price”). At any time, the Company may call the Replacement Notes for a cash amount equal to accrued interest plus (i) between the Closing and the first anniversary of the Closing, 120% of the then outstanding principal amount, (ii) between the first anniversary and the second anniversary of the Closing, 105% of the then outstanding principal amount and (iii) after the second anniversary of the Closing, the then outstanding principal amount of the Replacement Note. Further, the Replacement Notes permit the Company, in its discretion, to require conversion of the Replacement Notes into shares of Class A Common Stock if the daily volume-weighted average trading price of the Company Class A Common Stock exceeds 140% of the Conversion Price on each of at least ten consecutive trading days during the twenty trading day period prior to notice of such required conversion. The Company determined the embedded derivatives did not require bifurcation. Credova Subdebt Notes not exchanged for Replacement Notes at Closing were canceled following payment in full in cash. As of September 30, 2024, the convertible promissory notes payable was $8.4 million. Convertible Promissory Notes – Related Party In March 2024, the Company entered into a note purchase agreement for a 9.75% private placement convertible note for $10.0 million invested by a board member and his affiliates. Terms for the note were priced based on notes exchanged as part of the Credova Merger described above. In August 2024, the Company entered into an agreement for a $10.0 million convertible note in a private placement with a board member and affiliates. The note has identical terms to the notes offered in March 2024 (see Note 12). Convertible Promissory Notes The Company had issued convertible promissory notes (the “Note” or “Notes”) in the total amount of $22.5 million that accrued interest at the rate of 5% per annum until converted or paid in full upon maturity being December 31, 2024. As described in Note 1, on July 19, 2023, the Company consummated the Business Combination and became a publicly-traded company at which time the balance under each Note converted automatically into shares of PSQ Common Stock at a conversion price per share based upon an implied $100 million fully diluted pre-money valuation, excluding the Notes. The Notes are required to be recorded at their initial fair value on the date of issuance under ASC 480-10-25-14, and each balance sheet date thereafter. Changes in the estimated fair value of the Notes are recognized as non-cash gains or losses in the condensed consolidated statements of operations. The change in the fair value of the Notes measured with Level 3 inputs through September 30, 2023 are summarized as follows: Convertible Fair value as of January 1, 2023 $ — Principal balance of convertible notes issued 2,050,000 Change in valuation inputs or other assumptions 1,147,905 Fair value as of March 31, 2023 3,197,905 Principal balance of convertible notes issued 20,450,000 Change in valuation inputs or other assumptions 13,423,204 Fair value as of June 30, 2023 37,071,109 Conversion of convertible notes (37,071,109) Fair value as of September 30, 2023 $ — The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates: Exercise Price $ — Risk-Free Rate 4.1 % Maturity (in years) 1.8 Volatility 75.0 %

Leases

Leases	9 Months Ended
	Sep. 30, 2024
Leases [Abstract]
Leases	Leases As of September 30, 2024, the Company had three active leases for office suites: a short-term lease in California, a long-term lease in Florida set to expire in January 2025, and a long-term lease in Montana, detailed in the subsequent paragraph. The previous long-term California lease expired in August 2024. Termination of any lease is prohibited unless there is a violation under the lease agreement. The Florida lease has payments of $16,457 per month for the term of the lease. At lease commencement date, the Company estimated the lease liability and the right-of-use assets at present value using the Company’s estimated incremental borrowing rate of 10.5%. In conjunction with the Credova Merger, the Company acquired a lease agreement for its corporate office in Montana which had a commencement date of May 2022 and contains annual rent increases through April 2027. There is no purchase option or transfer of title of the leased premises at the end of the lease. The Company is responsible for all expenses, maintenance and taxes on the leased premises during the lease term. The Company has the option to renew the lease for an additional five-year period at prevailing rental rates at that time. In determining the length of the lease term, the Company did not include the optional renewal as on commencement date that renewal was not probable. At acquisition date, the Company estimated the lease liability and the right-of-use assets at present value using the Company’s estimated incremental borrowing rate of 9.75%. Rent expense under the operating leases included in the results of operations, inclusive of common area maintenance charges and real estate taxes, was approximately $0.1 million and $0.1 million for the three months ended September 30, 2024 and 2023, respectively, and approximately $0.4 million and $0.2 million for the nine months ended September 30, 2024 and 2023, respectively. The following amounts were recorded in the Company’s condensed consolidated balance sheets relating to its operating lease and other supplemental information: September 30, December 31, ROU assets $ 350,782 $ 324,238 Lease liabilities: Current lease liabilities $ 167,749 $ 310,911 Non-current lease liabilities 191,502 16,457 Total lease liabilities $ 359,251 $ 327,368 Other supplemental information: Weighted average remaining lease term 2.4 years 1 year Weighted average discount rate 10.0 % 10.5 % The following table presents the lease payments relating to the Company’s operating leases: Fiscal Year September 30, Remainder of 2024 $ 80,775 2025 144,273 2026 131,196 2027 44,112 Total lease payments 400,356 Less: imputed interest (41,105) Present value of operating lease liabilities $ 359,251

Warrant Liabilities

Warrant Liabilities	9 Months Ended
	Sep. 30, 2024
Warrant Liabilities [Abstract]
Warrant Liabilities	Warrant Liabilities As part of Colombier’s IPO, Colombier issued warrants to third-party investors where each whole warrant entitles the holder to purchase one share of the Company’s common stock at an exercise price of $11.50 per share (the “Public Warrants”). Simultaneously with the closing of the IPO, Colombier completed the private sale of warrants where each warrant allows the holder to purchase one share of the Company’s common stock at $11.50 per share. As of September 30, 2024 and December 31, 2023, there were 5,750,000 Public Warrants and 5,700,000 Private Placement warrants outstanding. These warrants expire on the fifth anniversary of the Business Combination or earlier upon redemption or liquidation and are exercisable commencing 30 days after the Business Combination, provided that the Company has an effective registration statement under the Securities Act covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. Once the warrants become exercisable, the Company may redeem the outstanding warrants: • in whole and not in part; • at a price of $0.01 per warrant; • upon not less than 30 days’ prior written notice of redemption given after the warrants become exercisable to each warrant holder; and • if, and only if, the reported last sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three The Public Warrants and Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognized the warrant instruments as liabilities at fair value as of the Closing Date, with an offsetting entry to additional paid-in capital and adjusts the carrying value of the instruments to fair value through other income (expense) on the condensed consolidated statement of operations at each reporting period until they are exercised. As of September 30, 2024 and December 31, 2023, the fair value of the Public Warrants and Private Placement Warrants liabilities are presented within warrant liabilities on the condensed consolidated balance sheet.

Related Parties

Related Parties	9 Months Ended
	Sep. 30, 2024
Related Party Transactions [Abstract]
Related Parties	Related Parties In March 2024, the Company entered into a 10-year note purchase agreement for a 9.75% private placement convertible note for $10.0 million invested by a board member and his affiliates. The private placement convertible note matures in March 2034. Terms for the note were priced based on notes exchanged as part of the Credova Merger. The Company’s stockholders have approved the issuance of the underlying shares as part of the annual stockholder meeting in April 2024 and the funds were received on May 3, 2024. In August 2024, the Company entered into an agreement for a $10.0 million 10-year convertible note in a private placement with a board member and affiliates. The funds were received on August 29, 2024. The private placement convertible note matures in August 2034. The note has identical terms to the notes offered in March 2024 (Note 9). In August 2023, the Company and its former Chief Operating Officer (“Former COO”) entered into a separation and release of claims agreement (the “Separation Agreement”) providing for the Former COO’s departure from his position to pursue other business opportunities. The effective date of the Former COO’s departure was August 25, 2023 (the “Separation Date”). Pursuant to the Separation Agreement, the Former COO is entitled to receive continued payment of his 2023 annual base salary for a period of 12 months, subject to his compliance with the Separation Agreement, including a release of claims in favor of the Company, certain restrictive covenants described below and the forfeiture to the Company by the Former COO of 1,704,223 shares of the Company’s Class A common stock. In addition, the Separation Agreement provides that the Former COO will not be granted further equity of the Company, including restricted stock units or earn-out compensation; however, the Former COO remains eligible to receive certain earn-out compensation as a former shareholder of PublicSq. Inc. Subject to eligibility, the Separation Agreement provides for continued payment by the Company of the Company’s share of COBRA premiums for the Former COO’s health benefit coverage for a period of up to 12 months following the Separation Date. The Separation Agreement also provides for, among other things, non-disclosure and non-solicitation obligations applicable to the Former COO and mutual non-disparagement obligations. In August 2023, the Company signed a one-year strategic consulting agreement, with a monthly auto-renewal feature thereafter, with a consulting company that is controlled by a board member. The consulting company was engaged by the Company to provide strategic advice and assistance to the Company in connection with capital markets strategy, acquisition strategy, investor relations strategy, and other strategic matters for a fixed fee of $80,000 per month plus expenses. As of January 1, 2024, the monthly amount was amended from $80,000 to $60,000 a month. As of September 30, 2024, the Company has incurred and paid $900,000 relating to this agreement. Please refer to Note 17 for additional information. In December 2023 the Company entered into a letter agreement (the “Letter Agreement”) with the same consulting company to engage the consulting company as an advisor to the Company in connection with the Credova Merger. The term of the Letter Agreement was the earlier of twelve (12) months from the date of the agreement or the consummation of the Credova Merger, which occurred on March 13, 2024. As consideration, the consulting company received $150,000 paid at the closing of the Credova Merger and 183,349 shares of Class A Common Stock, for a value of $887,809, in the Company with respect to the Credova Merger. In April 2024, the Company entered into a second letter agreement (the “Second Letter Agreement”) with the same strategic consulting company to engage the consulting company as an advisor to the Company in connection with potential acquisitions. The term of the Second Letter Agreement was the earlier of twelve (12) months from the date of the agreement or the consummation of an acquisition. As consideration, the consulting company will receive 1.5% of the total consideration paid for an acquisition. In June 2023, the Company signed a consulting agreement with a board member to provide advisory services to EveryLife. In exchange, the board member receives $10,000 per month and 40,000 RSUs that vest at the completion of the consulting agreement. On November 29, 2023, the Company entered into a new consulting agreement with the same board member, through his consulting company. In connection with the execution of the November 2023 consulting agreement, the previous consulting agreement was terminated. Pursuant to the November 2023 consulting agreement, the board member receives $30,000 per month and was granted 120,000 RSUs, subject to approval by the Company’s board, in connection with consulting services provided to the Company, including in regard to outreach, marketing and growth initiatives for the Company and EveryLife. Pursuant to the consulting agreement, 30,000 RSUs vested on January 31, 2024, 60,000 RSUs were to vest on May 3, 2024, and 30,000 RSUs will vest on November 1, 2024. On February 27, 2024, the November 2023 consulting agreement was amended to reduce the monthly fee from $30,000 to $15,000, and to remove the RSU grant of the 60,000 RSUs set to vest on May 3, 2024. For the three and nine months September 30, 2024, the Company has expensed $45,000 and $187,000, respectively, and paid approximately $30,000 and $172,000, respectively, relating to this agreement, including travel reimbursements.

Share Based Compensation

Share Based Compensation	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Share Based Compensation	Share Based Compensation On July 25, 2023, the Board of Directors of the Company approved the PSQ Holdings, Inc. 2023 Stock Incentive Plan (the “Plan”) as well as the 2023 Employee Stock Purchase Plan, whereby it may grant to certain employees, consultants and advisors an award, such as (a) incentive stock options, (b) non-qualified stock options, (c) restricted stock and (d) RSUs, of the Company. 2023 Stock incentive plan Awards may be made under the Plan for up to such number of shares of Class A Common Stock of the Company as is equal to the sum of: (A) a number of shares of Class A Common Stock equal to fifteen percent (15%) of the outstanding shares of all classes of Company Common Stock, determined immediately following the closing of the Merger Agreement. (B) an annual increase to be added on the first day of each fiscal year, commencing on January 1, 2024 and continuing for each fiscal year until, and including, January 1, 2033, equal to the lesser of (i) 5% of the outstanding shares of all classes of Company Common Stock on such date and (ii) the number of shares of Class A Common Stock determined by the Board. 2023 Employee Stock Purchase plan The purpose of this plan is to provide eligible employees opportunities to purchase shares of the Company’s Class A Common Stock. For this purpose, the Board approved 600,000 shares of Class A Common Stock, plus an annual increase to be added on the first day of each fiscal year, commencing on January 1, 2024 and continuing for each fiscal year until, and including, January 1, 2033, equal to the least of (i) 425,000 shares of Class A Common Stock, (ii) 1% of the outstanding shares of all classes of Company common stock, $0.0001 par value per share, on such date and (iii) a number of shares of Class A Common Stock determined by the Board. Restricted Stock Units There were no RSUs granted during the three and nine months ended September 30, 2023. During the three and nine months ended September 30, 2024, the Company issued RSU’s under the 2023 Stock Incentive Plan to employees, advisors, and board of directors. Each RSU entitles the recipient to one share of our common stock upon vesting. The Company measures the fair value of RSUs using the stock price on the date of grant. Share-based compensation expense for RSUs is recorded ratably over their vesting period. A summary of the activity with respect to, and status of, RSUs during the three and nine-month period ended September 30, 2024 is presented below: Number of Weighted Unvested as of January 1, 2024 1,655,542 $ 9.61 Granted 2,276,710 8.10 Forfeited (108,000) 10.12 Vested (638,629) 6.91 Unvested as of March 31, 2024 3,185,623 $ 8.93 Granted 490,140 3.48 Forfeited (5,000) 10.12 Vested (642,204) 6.44 Unvested as of June 30, 2024 3,028,559 $ 6.65 Granted 150,000 2.71 Forfeited (133,981) 7.01 Vested (609,336) 6.02 Unvested as of September 30, 2024 2,435,242 $ 6.64 As of September 30, 2024 and December 31, 2023 there were 5,023,858 and 2,354,989 RSUs outstanding, respectively. As of September 30, 2024, unrecognized compensation cost related to the grant of RSUs was approximately $19.2 million. Unvested outstanding RSUs as of September 30, 2024 had a weighted average remaining vesting period of 1.78. Share based compensation relating to earn-out In accordance with ASC 718, these are awards granted with a market condition. The effect of this market condition was reflected in the grant-date fair value of an award. The fair value of the earn-out shares was estimated using a Monte Carlo simulation utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Common Stock and current interest rates. Below are the key assumptions used in valuing the earn-out shares: As of PSQH Stock Price $ 9.08 Volatility 40.0 % Risk free rate of return 4.6 % Expected term (in years) 4.8 years The Company recorded $0.9 million and $2.7 million for the three and nine months ended September 30, 2024, respectively, of share-based compensation expense, related to the earn-out shares. As of September 30, 2024, unrecognized compensation cost related to the earn-out shares was approximately $13.1 million. During the three and nine months ended September 30, 2023, the Company recorded $0.8 million of share-based compensation expense, related to the earn-out shares. During the three and nine months ended September 30, 2024, the Company recorded the following share-based compensation expense, related to RSUs, earn-out shares and Credova Merger: For the For the Cost of sales $ 28,407 $ 108,392 General and administrative expenses 4,092,365 9,948,361 Research and development 411,470 1,149,456 Sales and marketing 1,264,581 4,761,388 Transaction costs incurred in connection with Credova Merger — 887,409 $ 5,796,823 $ 16,855,006 During the three and nine months ended September 30, 2023, the Company recorded the following share-based compensation expense, related to RSUs and earn-out shares: For the Cost of sales $ 2,239 General and administrative expenses 587,717 Research and development 201,810 Sales and marketing 393,323 Transaction incurred in connection with the Business Combination 910,800 $ 2,095,889

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company accounts for certain assets and liabilities at fair value and classifies these assets and liabilities within the fair value hierarchy (Level 1, Level 2, or Level 3). Assets and liabilities subject to fair value measurements are as follows: As of September 30, 2024 Level 1 Level 2 Level 3 Total Assets Cash and cash equivalents - Money market $ 2,523,424 $ — $ — $ 2,523,424 Liabilities Warrant liabilities - Public Warrants $ 1,207,500 $ — $ — $ 1,207,500 Warrant liabilities - Private placement warrants (1) — — 1,425,000 1,425,000 Earn-out liabilities (2) — — 150,000 150,000 Total liabilities $ 1,207,500 $ — $ 1,575,000 $ 2,782,500 As of December 31, 2023 Level 1 Level 2 Level 3 Total Assets Cash and cash equivalents - Money market $ 10,301,371 $ — $ — $ 10,301,371 Liabilities Warrant liabilities - Public Warrants $ 4,715,000 $ — $ — $ 4,715,000 Warrant liabilities - Private placement warrants (1) — — 5,415,000 5,415,000 Earn-out liabilities (2) — — 660,000 660,000 Total liabilities $ 4,715,000 $ — $ 6,075,000 $ 10,790,000 (1) Private Placement Warrants were estimated using a Black-Scholes option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Common Stock and current interest rates. (2) The fair value of the earn-out liabilities was estimated using Monte Carlo simulation utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Common Stock and current interest rates. The following tables present the changes in fair value of the private placements warrants: For the Liability at January 1, 2024 $ 5,415,000 Change in fair value (1,254,000) Balance as of March 31, 2024 4,161,000 Change in fair value (1,596,000) Balance as of June 30, 2024 2,565,000 Change in fair value (1,140,000) Balance as of September 30, 2024 $ 1,425,000 For the Liability at beginning of the period $ — Assumed in the Business Combination 4,389,000 Change in fair value 4,218,000 Balance as of September 30, 2023 $ 8,607,000 The following tables present the changes in fair value of the earn-out liabilities: For the Liability at January 1, 2024 $ 660,000 Change in fair value (120,000) Balance as of March 31, 2024 540,000 Change in fair value (220,000) Balance as of June 30, 2024 320,000 Change in fair value (170,000) Balance as of September 30, 2024 $ 150,000 For the Liability at beginning of the period $ — Assumed in the Business Combination 2,400,000 Change in fair value (450,000) Balance as of September 30, 2023 $ 1,950,000

Segments

Segments	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Segments	Segments The Company routinely evaluates whether its operating and reportable segments continue to reflect the way the CODM evaluates the business. The determination is based on: (1) how the Company’s CODM evaluates the performance of the business, including resource allocation decisions, and (2) whether discrete financial information for each operating segment is available. The Company considers the Chief Executive Officer to be its CODM. As of September 30, 2024, the Company’s operating and reportable segments include: • Marketplace: PSQ has created a marketplace platform to access consumers that are drawn to patriotic values. The Company generates revenue from advertising and e-commerce transaction revenues. • Brands: Our wholly owned brands include: • EveryLife, Inc., which generates revenue from online and wholesale sales of diapers and wipes. • PSQLink, LLC, which generates revenues through B2B sales, by providing its customers with a digital marketing and CRM platform. • Financial Technology: Our wholly owned Financial Technology subsidiaries include: • Credova Holdings, Inc., which generates revenue primarily through four activities: revenue from sale of loan and lease contracts, revenue from interest earned on loans, revenue from retailer discounts and origination fees paid by lending institutions (direct revenue) earned in connection with providing financing on consumer goods. • PSQPayments LLC (also referred to as “PublicSquare Payments”), is a wholly owned subsidiary of PSQH which will generate revenue from launching a merchant servicer platform to provide its customers with a payments stack which will comprise of a framework of technological components and services that the Company’s customers can utilize to manage their payment processes. The CODM measures and evaluates the Company’s performance based on segment gross revenue, segment gross profit margin and segment operating income, before interest, taxes, depreciation, and amortization (“EBITDA”). Adjusted EBITDA is defined as earnings (loss) from operations less depreciation and amortization, share based compensation and transaction costs. Earnings (loss) from operations excludes interest, interest expense, (gain) loss on sale of equipment, change in fair value of financial instruments and other expenses. The Company believes that Adjusted EBITDA is an appropriate measure for evaluating the operating performance of the Company’s business segments because it is the primary measure used by the Company’s chief operating decision maker to evaluate the performance of and allocate resources to the Company’s businesses. Segment performance, as defined by the Company, is not necessarily comparable to other similarly titled captions of other companies. The following tables set forth the Company’s revenues, net and direct contribution for the three and nine months ended September 30, 2024 and 2023: For the three months ended For the nine months ended 2024 2023 2024 2023 Revenues, net: Marketplace Advertising and e-commerce sales $ 717,692 $ 875,546 $ 2,389,801 $ 1,783,287 Brands Product sales 2,824,540 1,387,951 7,653,505 1,387,951 Other sales 18,789 — 37,527 — Returns and discounts (228,317) (232,597) (642,037) (232,597) Total Brand revenues, net 2,615,012 1,155,354 7,048,995 1,155,354 Financial Technology Direct revenue 1,150,951 — 2,272,818 — Interest income on loans 749,199 — 1,850,115 — Loan and lease contracts sold, net 1,307,258 — 2,429,500 — Total Financial Technology revenues, net 3,207,408 — 6,552,433 — Total revenues, net $ 6,540,112 $ 2,030,900 $ 15,991,229 $ 2,938,641 For the three months ended September 30, 2024 Marketplace Brands Financial Total Revenues, net $ 717,692 $ 2,615,012 $ 3,207,408 $ 6,540,112 Segment cost of revenues (582,614) (4,358) (22,298) (609,270) Segment cost of goods sold — (1,771,109) — (1,771,109) Segment gross profit 135,078 839,545 3,185,110 4,159,733 Segment operating costs (3,701,865) (1,457,446) (3,417,409) (8,576,720) Adjusted EBITDA (3,566,787) (617,901) (232,299) (4,416,987) Corporate operating expenses (3,503,643) Transaction costs incurred in connection with acquisitions — Share-based compensation (exclusive of what is included in transaction costs above) (5,796,823) Depreciation and amortization (975,090) Other expense, net (45,683) Change in fair value of convertible notes — Change in fair value of earn-out liabilities 170,000 Change in fair value of warrant liabilities 2,175,000 Interest expense, net (756,760) Income tax benefit 12,437 Net loss $ (13,137,549) For the three months ended September 30, 2023 Marketplace Brands Financial Total Revenues, net $ 875,546 $ 1,155,354 $ — $ 2,030,900 Segment cost of revenues (569,493) (9) — (569,502) Segment cost of goods sold — (903,672) — (903,672) Segment gross profit 306,053 251,673 — 557,726 Segment operating costs (2,871,552) (1,636,670) — (4,508,222) Adjusted EBITDA (2,565,499) (1,384,997) — (3,950,496) Corporate operating expenses (3,774,266) Transaction costs incurred in connection with the Business Combination (3,309,597) Share-based compensation (exclusive of what is included in transaction costs above) (1,185,089) Depreciation and amortization (759,745) Other income, net 119,957 Change in fair value of convertible notes — Change in fair value of earn-out liabilities 450,000 Change in fair value of warrant liabilities (7,783,000) Interest expense, net (46,690) Income tax benefit 262 Net loss $ (20,238,664) For the nine months ended September 30, 2024 Marketplace Brands Financial Total Revenues, net $ 2,389,801 $ 7,048,995 $ 6,552,433 $ 15,991,229 Segment cost of revenues (1,635,237) (4,358) (99,134) (1,738,729) Segment cost of goods sold — (4,601,360) — (4,601,360) Segment gross profit 754,564 2,443,277 6,453,299 9,651,140 Segment operating costs (9,807,606) (4,079,486) (6,992,869) (20,879,961) Adjusted EBITDA (9,053,042) (1,636,209) (539,570) (11,228,821) Corporate operating expenses (11,937,517) Transaction costs incurred in connection with acquisitions (2,295,502) Share-based compensation (exclusive of what is included in transaction costs above) (15,967,598) Depreciation and amortization (2,202,561) Other income, net 110,295 Change in fair value of convertible notes — Change in fair value of earn-out liabilities 510,000 Change in fair value of warrant liabilities 7,497,500 Interest expense, net (1,434,241) Income tax expense (1,181) Net loss $ (36,949,626) For the nine months ended September 30, 2023 Marketplace Brands Financial Total Revenues, net $ 1,783,287 $ 1,155,354 $ — $ 2,938,641 Segment cost of revenues (1,189,431) (9) — (1,189,440) Segment cost of goods sold — (903,672) — (903,672) Segment gross profit 593,856 251,673 — 845,529 Segment operating costs (6,445,931) (1,636,670) — (8,082,601) Adjusted EBITDA (5,852,075) (1,384,997) — (7,237,072) Corporate operating expenses (8,230,417) Transaction costs incurred in connection with the Business Combination (7,048,177) Share-based compensation (exclusive of what is included in transaction costs above) (1,185,089) Depreciation and amortization (2,004,319) Other income, net 173,644 Change in fair value of convertible notes (14,571,109) Change in fair value of earn-out liabilities 450,000 Change in fair value of warrant liabilities (7,783,000) Interest expense, net (210,545) Income tax expense (1,527) Net loss $ (47,647,611) No asset information has been disclosed as the CODM does not regularly review asset information by reportable segment.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Advertising Commitment In October 2023, the Company entered into a one-year advertising agreement with a media group for the purpose of promoting the Company and its services on a national platform. In connection with this agreement, the Company has committed to pay $1.0 million in six equal installments of $0.2 million. As of September 30, 2024, the Company has completed five of the six installments, for total amount paid of $0.8 million. In June 2024, the Company entered into a one-year advertising agreement with an independent media company for the purpose of promoting the Company and its services on a national platform. In connection with this agreement, the Company has committed to pay $0.8 million in twelve equal installments of $0.1 million. The Company canceled this contract in August 2024, and has no further commitments related to this agreement. As of September 30, 2024, the Company had completed three installments, for total amount paid of $0.2 million. Legal Proceedings The Company’s subsidiary, Credova, which the Company acquired on March 13, 2024, is responding to inquiries from the Consumer Financial Protection Bureau (CFPB) regarding Credova’s lease products. In connection with this, the CFPB informed Credova that it is authorized to pursue a resolution or file an enforcement action, and has suggested certain injunctive relief. No assurance can be given that a settlement will be reached or about the terms of any such settlement. At this time the Company is unable to state the exact nature of any relief that might be sought in any such action or resolution, including monetary relief or penalties, if any. From time to time in the ordinary course of business, the Company may be subject to various claims, charges, and litigation. At September 30, 2024, except as described in the preceding paragraph, the Company did not have any pending claims, charges or litigation that were expected to have a material adverse impact on its financial position, results of operations or cash flows.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events The Company has evaluated and recognized or disclosed subsequent events, as appropriate, from the condensed consolidated balance sheet date through the date the condensed consolidated financial statements were available to be issued. On October 6, 2024, the Company canceled its Business Summit, originally scheduled for October 10, 2024 to October 11, 2024, due to Hurricane Milton. As of September 30, 2024, the Company recorded advanced payments received for the Business Summit of $0.3 million in deferred revenue and prepayments for expenses of $1.2 million in prepaid expenses and other current assets in the accompanying condensed consolidated balance sheets with the intent they would be recognized in October 2024. Due to the cancellation, the related cash proceeds were returned to customers/merchants and approximately $0.9 million, or 72%, of the related cash disbursements were returned to the Company. On October 16, 2024, the Company amended the November 2023 consulting agreement referenced in Note 12 to reduce the monthly fee from $15,000 to zero. The monthly fee for October 2024 was prorated, and the full reduction in the fee will be effective November 1, 2024 On October 22, 2024, the Company completed the implementation of a strategic plan (the “Strategic Plan”) to streamline the organization, reducing staff by over 35% and focusing on the people critical to the Company’s B2B focused sales and marketing positioning going forward. The Company expects a non-recurring charge for severance of $0.4 million, in addition to one month of COBRA estimated to total $37,000 for those electing to utilize it, primarily incurred in the fourth quarter of 2024. The Company may incur additional costs not currently contemplated due to events associated with or resulting from the Strategic Plan. On October 24, 2024, the Company closed a private investment in public equity transaction (“PIPE”) pursuant to a Securities Purchase Agreement (“PIPE Purchase Agreement”) dated October 22, 2024, for the purchase of $5.35 million of Class A common stock at $2.70 per share with three investors: (i) an affiliate of a PSQH board member, (ii), a party related to a PSQH board member and executive officer, and (ii) an unaffiliated accredited investor (the “Purchasers”). The purchase price was slightly in excess of the 14-day average closing price of the Company’s stock on the New York Stock Exchange. The Purchasers also entered into a Registration Rights Agreement (the “PIPE Registration Rights Agreement”) with the Company, pursuant to which, among other things, require the Company to file a registration statement to register the resale of the shares within a certain period after the closing of the PIPE Purchase Agreement. The PIPE Purchase Agreement also contained a lock-up provision pursuant to which, for a period of 12 months after the closing of the PIPE Purchase Agreement, the shares will be subject to trading restrictions and the Purchasers will be restricted from selling short or hedging PSQ securities subject to certain exceptions. On October 28, 2024, the Company officially launched the PublicSquare Payments platform. On November 4, 2024, the first merchant transaction was successfully processed through the Company's proprietary gateway, leveraging an independent token vault and global scale processors.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) for interim financial information. Accordingly, certain information and footnote disclosures normally included in consolidated financial statements in accordance with U.S. GAAP have been omitted. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. All significant intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet at December 31, 2023 has been derived from the audited consolidated financial statements at that date, but does not include all disclosures, including notes, required by U.S. GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for its year ended December 31, 2023.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts and disclosures of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Estimates are adjusted to reflect actual experience when necessary. Such estimates include, but are not limited to, revenue recognition, allowance for credit losses, fair values of net assets acquired, intangible assets, inventory valuation, estimates related to useful lives of long-lived assets, estimation of contingencies, recoverability of deferred tax assets, the incremental borrowing rate applied to lease accounting, valuation of earn out liabilities and warrant liabilities, and estimation of income taxes. These estimates, judgments, and assumptions are reviewed periodically, and the impact of any revisions are reflected in the condensed consolidated financial statements in the period in which such revisions are made. Actual results could differ materially from those estimates, judgments, or assumptions, and such differences could be material to the Company’s consolidated financial position and results of operations.
Earnings (Loss) Per Share	Earnings (Loss) Per Share The Company computes basic loss per share (“EPS”) by dividing loss available to common stockholders by the weighted average number of common shares outstanding for the reporting period. All securities that meet the definition of a participating security, irrespective of whether the securities are convertible, nonconvertible, or potential common stock securities, shall be included in the computation of basic EPS using the two-class method. However, when the different classes of units have identical rights and privileges except voting rights, whereby they share equally in dividends and residual net assets on a per unit basis, the classes can be combined and presented as one class for EPS purposes. As such, the Company has combined the Class A and Class C Common stock for purposes of the EPS calculation. Diluted loss per share is calculated by dividing net loss by the weighted average number of common shares and dilutive common stock equivalents outstanding. During the periods when there are anti-dilutive, common stock equivalents, these are not considered in the computation. As of September 30, 2024, the Company’s restricted stock units (“RSUs”) and Warrants were not considered in the computation as they are anti-dilutive. As of September 30, 2024, there were no anti-dilutive shares or common stock equivalents outstanding.
Revenue Recognition	Revenue Recognition [1] Marketplace Revenues E-commerce revenues The Platform features a single cart shopping experience where consumers can purchase a variety of products from multiple vendors in one transaction. The Company is not the seller of record in these transactions. The commissions revenue earned from these arrangements is recognized on a net basis, which equates to the commission and processing fees earned in exchange for the seller marketplace services. The commission and processing fees are recognized net of estimated refunds when the buyer and seller confirm the corresponding transaction. The Company does not take title to inventory sold or assume risk of loss at any point in time during the transaction and is authorized to collect consideration from the buyer and remit net consideration to the seller to facilitate the processing of the confirmed purchase transaction. The Company currently records processing fees from its merchant service providers as a component of Cost of revenues on the condensed consolidated statement of operations. Advertising services The Company enters into advertising subscription arrangements with its customers. Revenue is recognized over-time as the ads are displayed over the subscription period. The Company is providing a service and the service is being consumed by the customer simultaneously over the period of service. In general, the Company reports advertising revenue on a gross basis, since the Company controls the advertising inventory before it is transferred to our customers. Our control is evidenced by our sole ability to monetize the advertising inventory before it is transferred to customers. The Company also sells push notifications and email blasts and recognizes revenue at a point in time when delivered. Push notifications and email blasts are considered delivered when an ad is displayed to users. When a customer enters into an advertising subscription arrangement that includes push notifications and/or email blasts, the Company allocates a portion of the total consideration to the push notification and email blast performance obligations based on the residual approach. In June 2024, the Company launched its cost per mille (“CPM”) advertising model. The advertising revenue related to CPM is recognized based on the number of impressions received from advertising on websites or mobile device applications, or as the advertiser’s previously agreed-upon performance criteria are satisfied. [2] Brand Revenues Product sales The Company generates revenue through the sale of diapers and wipes to consumers by way of the Company’s Platform and EveryLife’s website. Additionally, EveryLife provides discounted products to non-profit organizations and other strategic partners through bulk sales at discounted prices. The Company considers customer orders to be the contracts with the customer. There is a single performance obligation, which is the Company’s promise to transfer its product to customers based on specific payment and shipping terms in the arrangement. The entire transaction price is allocated to this single performance obligation. Product revenue is recognized when a customer obtains control of the product, which occurs at shipment. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. The Company evaluated principal versus agent considerations to determine whether it is appropriate to record third-party logistics provider fees paid as an expense. These fees are recorded as shipping and handling expenses within cost of goods sold and are not recorded as a reduction of revenue because the Company owns and controls all the goods before they are transferred to the customer. The Company can, at any time, direct the third-party logistics provider to return the Company’s inventories to any location specified by the Company. It is the Company’s responsibility to process any returns made by customers directly to logistic providers and the Company retains the back-end inventory risk. Further, the Company is subject to credit risk (i.e., credit card chargebacks), establishes prices of its products, fulfills the goods to the customer and can limit quantities or stop selling the goods at any time. Product Returns Consistent with industry practice, the Company generally offers customers a limited right of return for products purchased. The Company reviews its receivables quarterly and records a reserve, if necessary. As of September 30, 2024 and December 31, 2023, the Company had $0 and $15,000, respectively, recorded as an allowance for sales returns. B2B Sales PSQLink generates recurring software as a service (“SaaS”) revenues through B2B sales by providing its customers with a digital marketing and CRM platform. [3] Financial Technology Revenues Financing Revenues The Company principally generates financing revenue from four activities: revenue from sale of loan and lease contracts, revenue from interest earned on loans, revenue from retailer discounts, and origination fees paid by lending institutions (direct revenue) earned in connection with providing financing on consumer goods. Revenue from leases is recognized over time when the Company satisfies a performance obligation based on the agreed upon financing terms. Revenue from the Company’s sales of loans and leases is recognized at a point in time when the Company satisfies a performance obligation by transferring control of the loans to a third party. Interest on loans is calculated by the simple-interest method on daily balances of the principal amount outstanding. Revenue from retailer discounts is recognized at a point in time when the Company satisfies performance obligations by purchasing the contract from the merchant in connection with a merchant-originated consumer financing product. Origination fees from lenders are recognized at the time of loan origination.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with a maturity of 90 days or less at the time of purchase to be cash equivalents. The carrying values of cash and cash equivalents approximate their fair values due to the short-term nature of these instruments. The Company maintains cash accounts with financial institutions. At times, balances in these accounts may exceed federally insured limits. No losses have been incurred to date on any deposits.
Restricted cash	Restricted cash The Company has two Deposit Account Control Agreements (“DACA”) with lenders. With these agreements, the Company assigned the rights to a collateral account to the lenders. The DACA accounts are utilized to collect the consumer payments on loans and leases. Funds are then distributed in accordance with the loan security agreement. Funds cover payments for servicing, interest on revolving loans, and paying down revolving loans .
Loans held for Investment, net	Loans held for Investment, net Loans are unsecured and are stated at the amount of unpaid principal. Interest on loans is calculated by the simple-interest method on daily balances of the principal amount outstanding. Accrued interest on loans is discontinued when management believes that, after considering collection efforts and economic and business conditions, the collection of interest is doubtful. The Company’s policy is to stop accruing interest when the loan becomes 120 days’ delinquent. All interest accrued but not collected for loans that are placed on nonaccrual status or subsequently charged-off is reversed against interest income which is included in revenues, net on the condensed consolidated statements of operations. Income is subsequently recognized on the cash basis until, in management’s judgment, the borrower’s ability to make periodic and future principal and interest payments are reasonably assured, in which case the loan is returned to accrual status. The Company classifies its loans as either current or past due. Amounts are considered past due if a scheduled payment is not paid on its due date. The Company does not modify the terms of its existing loans with customers.
Allowance for credit losses Loans held for investment	Allowance for credit losses Loans held for investment The Company identifies its portfolio segments and measures the allowance for credit losses based on similar economic risk characteristics. The allowance for credit losses for each portfolio is determined based on the Company’s current estimate of expected credit losses over the remaining contractual term, adjusted for expected prepayments when appropriate, and incorporates evaluations of known and inherent risks in our portfolio, historical credit losses, consumer payment trends, estimates of recoveries, current economic conditions, and reasonable and supportable forecasts. Loans that do not share risk characteristics are evaluated on an individual basis. Loans evaluated individually are not included in the collective evaluation.
Business Combinations	Business Combinations The Company evaluates whether acquired net assets should be accounted for as a business combination or an asset acquisition by first applying a screen test to determine whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If so, the transaction is accounted for as an asset acquisition. If not, the Company applies its judgment to determine whether the acquired net assets meets the definition of a business by considering if the set includes an acquired input, process, and the ability to create outputs. The Company accounts for business combinations using the acquisition method when it has obtained control. The Company measures goodwill as the fair value of the consideration transferred including the fair value of any non-controlling interest recognized, less the net recognized amount of the identifiable assets acquired and liabilities assumed, all measured at their fair value as of the acquisition date. Transaction costs, other than those associated with the issuance of debt or equity securities, that the Company incurs in connection with a business combination are expensed as incurred. Any contingent consideration (“Earn-out liabilities”) is measured at fair value at the acquisition date. For contingent consideration that does not meet all the criteria for equity classification, such contingent consideration is required to be recorded at their initial fair value at the acquisition date, and on each balance sheet date thereafter. Changes in the estimated fair value of liability-classified contingent consideration are recognized on the condensed consolidated statements of operations in the period of change. When the initial accounting for a business combination has not been finalized by the end of the reporting period in which the transaction occurs, the Company reports provisional amounts. Provisional amounts are adjusted during the measurement period, which does not exceed one year from the acquisition date. These adjustments, or recognition of additional assets or liabilities, reflect new information obtained about facts and circumstances that existed at the acquisition date that, if known, would have affected the amounts recognized at that date.
Inventory	Inventory Inventory consists of finished goods and is stated at lower of cost or net realizable value. Cost is measured by using an adjusted standard cost method which approximates FIFO (first in, first out). The net realizable value of the Company’s inventory is estimated based on current and forecasted demand, and market conditions. The allowance for excess and obsolete inventory requires management to make assumptions and to apply judgment regarding a number of factors, including estimates applying past and projected sales performance to current inventory levels. As of September 30, 2024 and December 31, 2023, no reserve for inventory has been recorded.
Goodwill and acquired intangible assets	Goodwill and acquired intangible assets Goodwill in the Company’s condensed consolidated financial statements resulted from the Credova Merger, while the acquired intangible assets recorded in the Company’s condensed consolidated financial statements resulted from both the EveryLife asset acquisition and the Credova Merger. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed. Goodwill is not amortized as it is estimated to have an indefinite life. As such, goodwill is subject to an annual impairment test. The Company allocates goodwill to reporting units based on the expected benefit from the business combination. Reporting units are evaluated when changes in the Company’s operating structure occur, and if necessary, goodwill is reassigned using a relative fair value allocation approach. Accounting Standards Codification (“ASC”) 350, Intangibles—Goodwill and Other ("ASC 350") requires goodwill to be tested for impairment at least annually or more frequently if events or changes in circumstances indicate that goodwill may be impaired. The Company elects to perform an annual impairment test of goodwill as of December 31 of each year. The accounting guidance gives the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The qualitative assessment considers events and circumstances that might indicate that a reporting unit’s fair value is less than its carrying amount. If it is determined, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative test is performed. Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Acquired identifiable finite-lived intangible assets are amortized on a straight-line basis over the estimated useful life of the respective asset. Each period the Company evaluates the estimated remaining useful lives of its intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization. Acquired indefinite-lived intangible assets are not amortized but are tested for impairment at least annually or more frequently if events or changes in circumstances indicate that the intangible asset may be impaired.
Capitalized Software	Capitalized Software The Company capitalizes costs related to the development of its internal software and certain projects for internal use in accordance with ASC 350-40, Internal-Use Software
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets The Company reviews long-lived assets, including intangible assets, capitalized software and lease assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured first by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are impaired, an impairment loss would be recognized based on the excess of the carrying amount of the asset above the fair value of the asset. No impairment of the Company’s long-lived assets were recorded during the nine months ended September 30, 2024 and 2023.
Convertible Promissory Notes	Convertible Promissory Notes The Company may enter into convertible promissory notes, some of which contain predominantly fixed rate conversion features, whereby the holder may convert the outstanding principal and accrued interest into common shares at a fixed discount to the market price of the common stock at the time of conversion. In this case, the convertible promissory notes represent a financial instrument other than an outstanding share that embodies a conditional obligation that the issuer must or may settle by issuing a variable number of its equity shares. The Company records the convertible note liability at its fixed monetary amount by measuring and recording a premium, as applicable, on the convertible notes date with a charge to expense in accordance with ASC 480, Distinguishing Liabilities from Equity ("ASC 480").
Warrant Liabilities	Warrant Liabilities The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 815-40, Derivatives and Hedging (“ASC 815-40”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company accounts for the Public Warrants (as defined in Note 11) and the Private Placement Warrants (collectively, with the Public Warrants, the “Warrants”) in accordance with the guidance contained in ASC 815-40 under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each reporting period until exercised, and any change in fair value is recognized in the condensed consolidated statements of operations. The Warrants for periods where no observable traded price was available are valued using a Black-Scholes option pricing model. For the Public Warrants, quoted market price will be used as the fair value as of each relevant date.
Leases	Leases The Company determines if an arrangement is a lease at inception. For leases where the Company is the lessee, right-of-use (“ROU”) assets represent the Company’s right to use the underlying asset for the term of the lease and the lease liabilities represent an obligation to make lease payments arising from the lease. The Company’s lease agreement contains rent escalation provisions, which are considered in determining the ROU assets and lease liabilities. The Company begins recognizing rent expense when the lessor makes the underlying asset available for use by the Company. Lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments over the lease term. Lease renewal periods are considered on a lease-by-lease basis in determining the lease term. The interest rate the Company uses to determine the present value of future lease payments is the Company’s incremental borrowing rate because the rate implicit in the Company’s leases is not readily determinable. The incremental borrowing rate is a hypothetical rate for collateralized borrowings in economic environments where the leased asset is located based on credit rating factors. The ROU asset is determined based on the lease liability initially established and adjusted for any prepaid lease payments and any lease incentives received. The lease term to calculate the ROU asset and related lease liability includes options to extend or terminate the lease when it is reasonably certain that the Company will exercise the option. Certain leases contain variable costs, such as common area maintenance, real estate taxes or other costs. Variable lease costs are expensed as incurred on the condensed consolidated statements of operations. Operating leases are included in the ROU assets and lease liabilities on the condensed consolidated balance sheets. The Company has no finance leases.
Share Based Compensation	Share Based Compensation The Company recognizes an expense for share-based compensation awards based on the estimated fair value of the award on the date of grant. For certain awards, the Company has determined that the service inception date precedes the grant date as (a) the awards were authorized prior to establishing an accounting grant date, (b) the recipients began providing services prior to the grant date, and (c) there are performance conditions that, if not met by the accounting grant date, will result in the forfeiture of the awards. As the service inception date precedes the accounting grant date, the Company recognizes share-based compensation expense over the requisite service period based on the fair value on the award grant date.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is the price that would be received to sell an asset, or the amount paid to transfer a liability in an orderly transaction between market participants at the measurement date. There is a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The Company classifies fair value balances based on the observability of those inputs. The three levels of the fair value hierarchy are as follows: Level 1 - Inputs based on unadjusted quoted market prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets or quoted prices for identical or similar instruments in markets that are not active or for which all significant inputs are observable or can be corroborated by observable market data. Level 3 - Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are both unobservable for the asset and liability in the market and significant to the overall fair value measurement. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The Company establishes the fair value of its assets and liabilities using the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and establishes a fair value hierarchy based on the inputs used to measure fair value. The recorded amounts of certain financial instruments, including money markets classified as cash equivalents, accounts receivable, loans held for investment at fixed interest rates, accounts payable, accrued expenses, debt at fixed interest rates, and other liabilities approximate fair value due to their relatively short maturities. The Company’s policy is to record transfers between levels, if any, as of the beginning of the fiscal year. For the three and nine months ended September 30, 2024 and 2023 no transfers between levels have been recognized.
Segment Reporting	Segment Reporting Operating segments are defined as components of an entity for which separate discrete financial information is available that is evaluated regularly by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company has determined that the Company has three reportable segments comprised of Marketplace, Brands and Financial Technology.
Concentration of Risks	Concentration of Risks Financial instruments that potentially subject the Company to a significant concentration of credit risk consist primarily of cash and cash equivalents, and accounts receivable. Cash balances may exceed the FDIC insurance limit of $250,000. The Company has not experienced any losses in such accounts. For the three months ended September 30, 2024, one customer accounted for 10.6% of the Company’s revenue. For the three months ended September 30, 2023, no customer accounted for 10% or more of the Company’s revenue. For the nine months ended September 30, 2024 and 2023, no customer accounted for 10% or more of the Company’s revenue. As of September 30, 2024, one customer accounted for 18.5% of the Company’s accounts receivable. As of December 31, 2023, no customer accounted for 10% or more of the Company’s accounts receivable.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In March 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") No. 2024-01, Compensation—Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards (“ASU 2024-01”), which intends to improve clarity and comparability without changing the existing guidance. ASU 2024-01 provides an illustrative example intended to demonstrate how entities that account for profits interest and similar awards would determine whether a profits interest award should be accounted for in accordance with ASC 718, Compensation—Stock Compensation ("ASC 718"). Entities can apply the guidance either retrospectively to all prior periods presented in the financial statements or prospectively to profits interest and similar awards granted or modified on or after the date of adoption. ASU 2024-01 is effective for annual periods beginning after December 15, 2024, and interim periods within those annual periods. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is currently evaluating the potential impact of adopting ASU 2024-01 on its condensed consolidated financial statements. In November 2024, the FASB issued ASU No. 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03") , which is intended to improve the disclosures of expenses by providing more detailed information about the types of expenses in commonly presented expense captions. The ASU requires entities to disclose the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization included in each relevant expense caption; as well as a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. The amendment also requires disclosure of the total amount of selling expense and, in annual reporting periods, an entity’s definition of selling expenses. The ASU is effective for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027; however early adoption is permitted. The ASU can be applied either prospectively or retrospectively. The Company is currently evaluating the potential impact of adopting ASU 2024-01 on its condensed consolidated financial statements. The Company has assessed the adoption impacts of recently issued accounting standards by the FASB on the Company’s condensed consolidated financial statements as well as material updates to previous assessments, if any, to the Company’s annual audited consolidated financial statements and notes thereto included in our Form 10-K for the year ended December 31, 2023.

Recapitalization (Tables)

Recapitalization (Tables)	9 Months Ended
	Sep. 30, 2024
Recapitalization [Abstract]
Schedule of Business Combination to the Condensed Consolidated Statements of Cash Flows	The following table reconciles the elements of the Business Combination to the condensed consolidated statements of cash flows and the condensed consolidated statement of changes in stockholders’ equity: Cash-trust and cash, net of redemptions $ 34,938,880 Less: transaction costs and advisory fees, paid (16,834,686) Net proceeds from the Business Combination 18,104,194 Less: public and private placement warrant liabilities (8,816,500) Less: earn-out liabilities (2,400,000) Add: amounts paid in advance 2,570,919 Add: Transaction costs in accounts payable and accrued expenses 2,967,393 Reverse recapitalization, net $ 12,426,006
Schedule of Common Stock Issued	The number of shares of Common Stock issued immediately following the consummation of the Business Combination were: Colombier Class A common stock, outstanding prior to the Business Combination 17,250,000 Less: Redemption of Colombier Class A common stock (13,827,349) Class A common stock of Colombier 3,422,651 Colombier Class B common stock, outstanding prior to the Business Combination 4,312,500 Business Combination shares 7,735,151 PSQ Shares 21,522,825 Common Stock immediately after the Business Combination 29,257,976
Schedule of Number of PSQ Shares	The number of PSQ shares was determined as follows: PSQ Shares PSQ Class A Common Stock 940,044 18,309,147 Class C Common Stock 165,000 3,213,678 Total 1,105,044 21,522,825

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
	Sep. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Schedule of Purchase Price Allocation as of the Acquisition Date	The purchase price allocation as of the acquisition date is presented as follows: March 13, Purchase consideration: Common Stock, at fair value $ 14,137,606 Assumption of notes payable 8,449,500 Cash paid 1,587,184 Total purchase consideration $ 24,174,290 Purchase price allocation: Cash $ 1,728,400 Loans held for investment 7,027,678 Fixed assets 243,879 Intangible assets 11,720,000 Prepaid expenses 1,269,933 Goodwill 10,930,978 Operating lease right of use asset 341,121 Accounts payable and other current liabilities (3,430,171) Lease liability (341,121) Revolving line of credit (5,316,407) Fair value of net assets acquired $ 24,174,290
Schedule of Intangible Assets Acquired Estimated Useful Lives Date of Acquisition	The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition (in years): Fair value Useful life Trademarks and Tradenames $ 1,700,000 5 Internally developed software 3,600,000 3 Merchant relationships 5,900,000 5 State operating licenses 520,000 Indefinite Total intangible assets $ 11,720,000
Schedule of Pro Forma Financial Information	The following unaudited supplemental pro forma combined financial information presents the Company’s combined results of operations for the three and nine months ended September 30, 2024 and 2023 as if the Credova Merger had occurred on January 1, 2023. The pro forma financial information is presented for comparative purposes only and is not necessarily indicative of the Company’s operating results that may have occurred had the Credova Merger been completed on January 1, 2023. In addition, the unaudited pro forma financial information does not give effect to any anticipated cost savings, operating efficiencies or other synergies that may be associated with the merger, or any estimated costs that have been or will be incurred by the Company to integrate the assets and operations of Credova. Three months Nine months Revenue $ 6,540,112 $ 18,904,794 Net loss $ (13,137,549) $ (35,558,372) Three months Nine months Revenue $ 5,600,958 $ 13,895,120 Net loss $ (20,987,828) $ (52,109,581)
Schedule of Acquisition Date Fair Value of Asset Acquired	The following table presents the acquisition date fair value of the asset acquired: Assets acquired: Balance - January 1, 2023 $ — Issuance of common stock at fair value 1,334,850 Legal costs capitalized 42,611 Balance - December 31, 2023 $ 1,377,461

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets, Net	The following table summarizes intangible assets, net: Useful September 30, December 31, Capitalized software development costs 1-5 years $ 7,748,105 $ 5,011,519 Trademark and tradenames 5 years 1,700,000 — Internally developed software 3 years 3,600,000 — Merchant relationships 5 years 5,900,000 — State operating licenses Indefinite 520,000 — Purchased technology 1-15 years 247,489 247,489 Brand name 10 years 1,377,461 1,377,461 Total intangible assets 21,093,055 6,636,469 Less: Accumulated amortization (5,144,677) (3,079,440) Total intangible assets, net $ 15,948,378 $ 3,557,029
Schedule of Estimated Future Amortization Expense	As of September 30, 2024, estimated future amortization expense is expected as follows: Remainder of 2024 $ 1,168,960 2025 3,793,004 2026 3,793,004 2027 2,791,739 2028 2,894,054 Thereafter 1,507,617 $ 15,948,378

Loans Held for Investment, Net

Loans Held for Investment, Net (Tables)	9 Months Ended
	Sep. 30, 2024
Receivables [Abstract]
Schedule of Company’s Loans Held for Investment	Past Due Current 30-59 Days 60-89 days > 90 days Total Loans held for investment $ 4,770,333 $ 66,839 $ 46,173 $ 30,029 $ 4,913,374 Allowance for credit losses (665,142) Loans held for investment, net $ 4,248,232
Schedule of Allowance for Credit Losses on Loans Held for Investment	The changes in allowance for credit losses on loans held for investment as of September 30, 2024 is as follows: Balance at January 1, 2024 $ — Balance acquired from Credova Merger 1,130,515 Charge-offs (1,015,358) Provision for credit losses 549,985 Balance at September 30, 2024 $ 665,142

Convertible Promissory Notes (T

Convertible Promissory Notes (Tables)	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Schedule of Change in the Fair Value of the Notes Measured with Level 3 Inputs	The change in the fair value of the Notes measured with Level 3 inputs through September 30, 2023 are summarized as follows: Convertible Fair value as of January 1, 2023 $ — Principal balance of convertible notes issued 2,050,000 Change in valuation inputs or other assumptions 1,147,905 Fair value as of March 31, 2023 3,197,905 Principal balance of convertible notes issued 20,450,000 Change in valuation inputs or other assumptions 13,423,204 Fair value as of June 30, 2023 37,071,109 Conversion of convertible notes (37,071,109) Fair value as of September 30, 2023 $ —
Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs	The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates: Exercise Price $ — Risk-Free Rate 4.1 % Maturity (in years) 1.8 Volatility 75.0 %

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2024
Leases [Abstract]
Schedule of Operating Lease and Other Supplemental Information	The following amounts were recorded in the Company’s condensed consolidated balance sheets relating to its operating lease and other supplemental information: September 30, December 31, ROU assets $ 350,782 $ 324,238 Lease liabilities: Current lease liabilities $ 167,749 $ 310,911 Non-current lease liabilities 191,502 16,457 Total lease liabilities $ 359,251 $ 327,368 Other supplemental information: Weighted average remaining lease term 2.4 years 1 year Weighted average discount rate 10.0 % 10.5 %
Schedule of Lease Payments Relating to the Company’s Operating Leases	The following table presents the lease payments relating to the Company’s operating leases: Fiscal Year September 30, Remainder of 2024 $ 80,775 2025 144,273 2026 131,196 2027 44,112 Total lease payments 400,356 Less: imputed interest (41,105) Present value of operating lease liabilities $ 359,251

Share Based Compensation (Table

Share Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Activity with Respect to, and Status of, RSUs	A summary of the activity with respect to, and status of, RSUs during the three and nine-month period ended September 30, 2024 is presented below: Number of Weighted Unvested as of January 1, 2024 1,655,542 $ 9.61 Granted 2,276,710 8.10 Forfeited (108,000) 10.12 Vested (638,629) 6.91 Unvested as of March 31, 2024 3,185,623 $ 8.93 Granted 490,140 3.48 Forfeited (5,000) 10.12 Vested (642,204) 6.44 Unvested as of June 30, 2024 3,028,559 $ 6.65 Granted 150,000 2.71 Forfeited (133,981) 7.01 Vested (609,336) 6.02 Unvested as of September 30, 2024 2,435,242 $ 6.64
Schedule of Common Stock and Current Interest Rates	The fair value of the earn-out shares was estimated using a Monte Carlo simulation utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Common Stock and current interest rates. Below are the key assumptions used in valuing the earn-out shares: As of PSQH Stock Price $ 9.08 Volatility 40.0 % Risk free rate of return 4.6 % Expected term (in years) 4.8 years
Schedule of Share-Based Compensation Expense	During the three and nine months ended September 30, 2024, the Company recorded the following share-based compensation expense, related to RSUs, earn-out shares and Credova Merger: For the For the Cost of sales $ 28,407 $ 108,392 General and administrative expenses 4,092,365 9,948,361 Research and development 411,470 1,149,456 Sales and marketing 1,264,581 4,761,388 Transaction costs incurred in connection with Credova Merger — 887,409 $ 5,796,823 $ 16,855,006 During the three and nine months ended September 30, 2023, the Company recorded the following share-based compensation expense, related to RSUs and earn-out shares: For the Cost of sales $ 2,239 General and administrative expenses 587,717 Research and development 201,810 Sales and marketing 393,323 Transaction incurred in connection with the Business Combination 910,800 $ 2,095,889

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Subject to Fair Value Measurements	Assets and liabilities subject to fair value measurements are as follows: As of September 30, 2024 Level 1 Level 2 Level 3 Total Assets Cash and cash equivalents - Money market $ 2,523,424 $ — $ — $ 2,523,424 Liabilities Warrant liabilities - Public Warrants $ 1,207,500 $ — $ — $ 1,207,500 Warrant liabilities - Private placement warrants (1) — — 1,425,000 1,425,000 Earn-out liabilities (2) — — 150,000 150,000 Total liabilities $ 1,207,500 $ — $ 1,575,000 $ 2,782,500 As of December 31, 2023 Level 1 Level 2 Level 3 Total Assets Cash and cash equivalents - Money market $ 10,301,371 $ — $ — $ 10,301,371 Liabilities Warrant liabilities - Public Warrants $ 4,715,000 $ — $ — $ 4,715,000 Warrant liabilities - Private placement warrants (1) — — 5,415,000 5,415,000 Earn-out liabilities (2) — — 660,000 660,000 Total liabilities $ 4,715,000 $ — $ 6,075,000 $ 10,790,000 (1) Private Placement Warrants were estimated using a Black-Scholes option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Common Stock and current interest rates. (2) The fair value of the earn-out liabilities was estimated using Monte Carlo simulation utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Common Stock and current interest rates.
Schedule of Changes in Fair Value of the Public and Private Placements Warrants	The following tables present the changes in fair value of the private placements warrants: For the Liability at January 1, 2024 $ 5,415,000 Change in fair value (1,254,000) Balance as of March 31, 2024 4,161,000 Change in fair value (1,596,000) Balance as of June 30, 2024 2,565,000 Change in fair value (1,140,000) Balance as of September 30, 2024 $ 1,425,000 For the Liability at beginning of the period $ — Assumed in the Business Combination 4,389,000 Change in fair value 4,218,000 Balance as of September 30, 2023 $ 8,607,000 The following tables present the changes in fair value of the earn-out liabilities: For the Liability at January 1, 2024 $ 660,000 Change in fair value (120,000) Balance as of March 31, 2024 540,000 Change in fair value (220,000) Balance as of June 30, 2024 320,000 Change in fair value (170,000) Balance as of September 30, 2024 $ 150,000 For the Liability at beginning of the period $ — Assumed in the Business Combination 2,400,000 Change in fair value (450,000) Balance as of September 30, 2023 $ 1,950,000

Segments (Tables)

Segments (Tables)	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Schedule of Segment 's Adjusted EBITDA	The following tables set forth the Company’s revenues, net and direct contribution for the three and nine months ended September 30, 2024 and 2023: For the three months ended For the nine months ended 2024 2023 2024 2023 Revenues, net: Marketplace Advertising and e-commerce sales $ 717,692 $ 875,546 $ 2,389,801 $ 1,783,287 Brands Product sales 2,824,540 1,387,951 7,653,505 1,387,951 Other sales 18,789 — 37,527 — Returns and discounts (228,317) (232,597) (642,037) (232,597) Total Brand revenues, net 2,615,012 1,155,354 7,048,995 1,155,354 Financial Technology Direct revenue 1,150,951 — 2,272,818 — Interest income on loans 749,199 — 1,850,115 — Loan and lease contracts sold, net 1,307,258 — 2,429,500 — Total Financial Technology revenues, net 3,207,408 — 6,552,433 — Total revenues, net $ 6,540,112 $ 2,030,900 $ 15,991,229 $ 2,938,641 For the three months ended September 30, 2024 Marketplace Brands Financial Total Revenues, net $ 717,692 $ 2,615,012 $ 3,207,408 $ 6,540,112 Segment cost of revenues (582,614) (4,358) (22,298) (609,270) Segment cost of goods sold — (1,771,109) — (1,771,109) Segment gross profit 135,078 839,545 3,185,110 4,159,733 Segment operating costs (3,701,865) (1,457,446) (3,417,409) (8,576,720) Adjusted EBITDA (3,566,787) (617,901) (232,299) (4,416,987) Corporate operating expenses (3,503,643) Transaction costs incurred in connection with acquisitions — Share-based compensation (exclusive of what is included in transaction costs above) (5,796,823) Depreciation and amortization (975,090) Other expense, net (45,683) Change in fair value of convertible notes — Change in fair value of earn-out liabilities 170,000 Change in fair value of warrant liabilities 2,175,000 Interest expense, net (756,760) Income tax benefit 12,437 Net loss $ (13,137,549) For the three months ended September 30, 2023 Marketplace Brands Financial Total Revenues, net $ 875,546 $ 1,155,354 $ — $ 2,030,900 Segment cost of revenues (569,493) (9) — (569,502) Segment cost of goods sold — (903,672) — (903,672) Segment gross profit 306,053 251,673 — 557,726 Segment operating costs (2,871,552) (1,636,670) — (4,508,222) Adjusted EBITDA (2,565,499) (1,384,997) — (3,950,496) Corporate operating expenses (3,774,266) Transaction costs incurred in connection with the Business Combination (3,309,597) Share-based compensation (exclusive of what is included in transaction costs above) (1,185,089) Depreciation and amortization (759,745) Other income, net 119,957 Change in fair value of convertible notes — Change in fair value of earn-out liabilities 450,000 Change in fair value of warrant liabilities (7,783,000) Interest expense, net (46,690) Income tax benefit 262 Net loss $ (20,238,664) For the nine months ended September 30, 2024 Marketplace Brands Financial Total Revenues, net $ 2,389,801 $ 7,048,995 $ 6,552,433 $ 15,991,229 Segment cost of revenues (1,635,237) (4,358) (99,134) (1,738,729) Segment cost of goods sold — (4,601,360) — (4,601,360) Segment gross profit 754,564 2,443,277 6,453,299 9,651,140 Segment operating costs (9,807,606) (4,079,486) (6,992,869) (20,879,961) Adjusted EBITDA (9,053,042) (1,636,209) (539,570) (11,228,821) Corporate operating expenses (11,937,517) Transaction costs incurred in connection with acquisitions (2,295,502) Share-based compensation (exclusive of what is included in transaction costs above) (15,967,598) Depreciation and amortization (2,202,561) Other income, net 110,295 Change in fair value of convertible notes — Change in fair value of earn-out liabilities 510,000 Change in fair value of warrant liabilities 7,497,500 Interest expense, net (1,434,241) Income tax expense (1,181) Net loss $ (36,949,626) For the nine months ended September 30, 2023 Marketplace Brands Financial Total Revenues, net $ 1,783,287 $ 1,155,354 $ — $ 2,938,641 Segment cost of revenues (1,189,431) (9) — (1,189,440) Segment cost of goods sold — (903,672) — (903,672) Segment gross profit 593,856 251,673 — 845,529 Segment operating costs (6,445,931) (1,636,670) — (8,082,601) Adjusted EBITDA (5,852,075) (1,384,997) — (7,237,072) Corporate operating expenses (8,230,417) Transaction costs incurred in connection with the Business Combination (7,048,177) Share-based compensation (exclusive of what is included in transaction costs above) (1,185,089) Depreciation and amortization (2,004,319) Other income, net 173,644 Change in fair value of convertible notes (14,571,109) Change in fair value of earn-out liabilities 450,000 Change in fair value of warrant liabilities (7,783,000) Interest expense, net (210,545) Income tax expense (1,527) Net loss $ (47,647,611)

Organization and Business Ope_2

Organization and Business Operations (Details)	9 Months Ended
	Sep. 30, 2024 segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of operating segments	3

Liquidity (Details)

Liquidity (Details)			1 Months Ended	3 Months Ended						9 Months Ended
	Oct. 24, 2024 USD ($) investor $ / shares	Oct. 22, 2024	Oct. 31, 2024 USD ($)	Sep. 30, 2024 USD ($)	Jun. 30, 2024 USD ($)	Mar. 31, 2024 USD ($)	Sep. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Dec. 31, 2023 USD ($)
Subsequent Event [Line Items]
Net loss				$ 13,137,549	$ 11,235,246	$ 12,576,831	$ 20,238,664	$ 20,721,307	$ 6,687,640	$ 36,949,626	$ 47,647,611
Net cash used in operating activities										27,127,434	18,412,328
Unrestricted cash and cash equivalents				4,709,237			$ 25,255,909			4,709,237	$ 25,255,909	$ 16,446,030
Working capital				$ 7,500,000						$ 7,500,000		$ 17,200,000
Subsequent Event
Subsequent Event [Line Items]
Common stock sold, aggregate purchase price	$ 5,350,000
Price per share (in dollars per share) | $ / shares	$ 2.70
Number of investors | investor	3
Number of positions eliminated, period percent		35%	35%
Expected annual cash savings			$ 11,000,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) segment	Sep. 30, 2023 USD ($)	Dec. 31, 2023 USD ($)
Variable Interest Entity [Line Items]
Product returns reserve	$ 0		$ 0		$ 15,000
Research and development expense	$ 80,000	$ 80,000	200,000	$ 1,000,000
Impairment of long-lived assets			$ 0	$ 0
Number of reportable segments | segment			3
One Customer | Revenue from Contract with Customer Benchmark | Customer Concentration Risk
Variable Interest Entity [Line Items]
Concentration risk			10.60%
One Customer | Accounts Receivable | Customer Concentration Risk
Variable Interest Entity [Line Items]
Concentration risk			18.50%

Recapitalization - Narrative (D

Recapitalization - Narrative (Details)	9 Months Ended
	Sep. 30, 2024 USD ($) day $ / shares shares	Dec. 31, 2023 $ / shares shares
Recapitalization [Line Items]
Business combination gross proceeds | $	$ 34,900,000
Total transaction costs | $	$ 16,800,000
CEO
Recapitalization [Line Items]
Ownership, percentage	100%
Per Share Class C Voting Power
Recapitalization [Line Items]
Voting power percentage	52.62%
PSQ Common Stocks
Recapitalization [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 0.001
Class A Common Stock
Recapitalization [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Right to receive shares (in shares)	19.476836
Shares issued (in shares)	29,451,684	24,410,075
Earnout trading price (in dollars per share) | $ / shares	$ 12.50
Earnout (in shares)	1,000,000
Redemption (in shares)	13,827,349
Aggregate payment | $	$ 141,151,432
Class A Common Stock | PSQ Common Stocks
Recapitalization [Line Items]
Shares issued (in shares)	3,000,000
Earnout period	5 years
Number of trading days | day	20
Number of consecutive trading days | day	30
Class A Common Stock | CEO
Recapitalization [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001
Class C Common Stock
Recapitalization [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Shares issued (in shares)	3,213,678	3,213,678
Class C Common Stock | CEO
Recapitalization [Line Items]
Right to receive shares (in shares)	19.476836
Class A Common Stock One
Recapitalization [Line Items]
Earnout trading price (in dollars per share) | $ / shares	$ 15
Earnout (in shares)	1,000,000
Class A Common Stock Two
Recapitalization [Line Items]
Earnout trading price (in dollars per share) | $ / shares	$ 17.50
Earnout (in shares)	1,000,000
IPO | Private Placement Warrants
Recapitalization [Line Items]
Warrants outstanding (in shares)	5,700,000

Recapitalization - Schedule of

Recapitalization - Schedule of Business Combination to the Condensed Consolidated Statements of Cash Flows (Details)	Sep. 30, 2024 USD ($)
Business Combination, Separately Recognized Transactions [Line Items]
Less: transaction costs and advisory fees, paid	$ 16,800,000
Consolidated Cash Flow
Business Combination, Separately Recognized Transactions [Line Items]
Cash-trust and cash, net of redemptions	34,938,880
Less: transaction costs and advisory fees, paid	(16,834,686)
Net proceeds from the Business Combination	18,104,194
Less: public and private placement warrant liabilities	(8,816,500)
Less: earn-out liabilities	(2,400,000)
Add: amounts paid in advance	2,570,919
Add: Transaction costs in accounts payable and accrued expenses	2,967,393
Reverse recapitalization, net	$ 12,426,006

Recapitalization - Schedule o_2

Recapitalization - Schedule of Common Stock Issued (Details)	Sep. 30, 2024 shares
Common Class A and B
Business Combination Segment Allocation [Line Items]
Business Combination shares (in shares)	7,735,151
PSQ Shares (in shares)	21,522,825
Common Stock immediately after the Business Combination (in shares)	29,257,976
Class A Common Stock
Business Combination Segment Allocation [Line Items]
Colombier Class A common stock, outstanding prior to the Business Combination (in shares)	17,250,000
Less: Redemption of Colombier Class A common stock (in shares)	(13,827,349)
Class A common stock of Colombier (in shares)	3,422,651
Class B Common Stock
Business Combination Segment Allocation [Line Items]
Colombier Class A common stock, outstanding prior to the Business Combination (in shares)	4,312,500

Recapitalization - Schedule o_3

Recapitalization - Schedule of Number of PSQ Shares (Details) - shares	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Class A Common Stock
Business Acquisition [Line Items]
PSQ Shares (in shares)	29,451,684	24,410,075
Class C Common Stock
Business Acquisition [Line Items]
PSQ Shares (in shares)	3,213,678	3,213,678
PSQ Shares
Business Acquisition [Line Items]
PSQ Shares (in shares)	1,105,044
PSQ Shares after conversion ratio (in shares)	21,522,825
PSQ Shares | Class A Common Stock
Business Acquisition [Line Items]
PSQ Shares (in shares)	940,044
PSQ Shares after conversion ratio (in shares)	18,309,147
PSQ Shares | Class C Common Stock
Business Acquisition [Line Items]
PSQ Shares (in shares)	165,000
PSQ Shares after conversion ratio (in shares)	3,213,678

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Details) - USD ($) $ in Millions		3 Months Ended	9 Months Ended
	Mar. 13, 2024	Sep. 30, 2024	Sep. 30, 2024	Feb. 28, 2023
Asset Acquisition [Line Items]
Consideration shares equal percent	10%
Acquisition-related costs			$ 2.3
Revenue		$ 3.2	6.6
Net income		$ 1.1	$ 2.5
Shares exchange (in shares)				1,071,229
Escrow Shares
Asset Acquisition [Line Items]
Newly issued shares (in shares)	2,920,993

Acquisitions - Schedule of Purc

Acquisitions - Schedule of Purchase Price Allocation as of the Acquisition Date (Details) - USD ($)		3 Months Ended
	Mar. 13, 2024	Mar. 31, 2024	Sep. 30, 2023	Sep. 30, 2024	Dec. 31, 2023
Purchase consideration:
Common Stock, at fair value		$ 14,137,606	$ 12,426,780
Purchase price allocation:
Goodwill				$ 10,930,978	$ 0
Credova
Purchase consideration:
Common Stock, at fair value	$ 14,137,606
Assumption of notes payable	8,449,500
Cash paid	1,587,184
Total purchase consideration	24,174,290
Purchase price allocation:
Cash	1,728,400
Loans held for investment	7,027,678
Fixed assets	243,879
Intangible assets	11,720,000
Prepaid expenses	1,269,933
Goodwill	10,930,978
Operating lease right of use asset	341,121
Accounts payable and other current liabilities	(3,430,171)
Lease liability	(341,121)
Revolving line of credit	(5,316,407)
Fair value of net assets acquired	$ 24,174,290

Acquisitions - Schedule of Inta

Acquisitions - Schedule of Intangible Assets Acquired Estimated Useful Lives Date of Acquisition (Details)	9 Months Ended
	Sep. 30, 2024 USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]
State operating licenses	$ 520,000
Total intangible assets	11,720,000
Trademark and tradenames
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets acquired	$ 1,700,000
Useful life	5 years
Internally developed software
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets acquired	$ 3,600,000
Useful life	3 years
Merchant relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets acquired	$ 5,900,000
Useful life	5 years

Acquisitions - Schedule of Pro

Acquisitions - Schedule of Pro Forma Financial Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Revenue	$ 6,540,112	$ 5,600,958	$ 18,904,794	$ 13,895,120
Net loss	$ (13,137,549)	$ (20,987,828)	$ (35,558,372)	$ (52,109,581)

Acquisitions - Schedule of Acqu

Acquisitions - Schedule of Acquisition Date Fair Value of Asset Acquired (Details)	12 Months Ended
	Dec. 31, 2023 USD ($)
Assets acquired:
Balance - January 1, 2023	$ 0
Issuance of common stock at fair value	1,334,850
Legal costs capitalized	42,611
Balance - December 31, 2023	$ 1,377,461

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 10,930,978		$ 10,930,978		$ 0
Amortization expenses	$ 900,000	$ 700,000	$ 2,100,000	$ 2,000,000

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net - Schedule of Intangible Assets, Net (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
State operating licenses	$ 520,000	$ 0
Total intangible assets	21,093,055	6,636,469
Less: Accumulated amortization	(5,144,677)	(3,079,440)
Total intangible assets, net	15,948,378	3,557,029
Capitalized software development costs
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets	$ 7,748,105	5,011,519
Trademark and tradenames
Finite-Lived Intangible Assets [Line Items]
Useful Life	5 years
Finite-lived intangible assets	$ 1,700,000	0
Internally developed software
Finite-Lived Intangible Assets [Line Items]
Useful Life	3 years
Finite-lived intangible assets	$ 3,600,000	0
Merchant relationships
Finite-Lived Intangible Assets [Line Items]
Useful Life	5 years
Finite-lived intangible assets	$ 5,900,000	0
Purchased technology
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets	$ 247,489	247,489
Brand name
Finite-Lived Intangible Assets [Line Items]
Useful Life	10 years
Finite-lived intangible assets	$ 1,377,461	$ 1,377,461
Minimum | Capitalized software development costs
Finite-Lived Intangible Assets [Line Items]
Useful Life	1 year
Minimum | Purchased technology
Finite-Lived Intangible Assets [Line Items]
Useful Life	1 year
Maximum | Capitalized software development costs
Finite-Lived Intangible Assets [Line Items]
Useful Life	5 years
Maximum | Purchased technology
Finite-Lived Intangible Assets [Line Items]
Useful Life	15 years

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net - Schedule of Estimated Future Amortization Expense (Details)	Sep. 30, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2024	$ 1,168,960
2025	3,793,004
2026	3,793,004
2027	2,791,739
2028	2,894,054
Thereafter	1,507,617
Total	$ 15,948,378

Loans Held for Investment, Ne_2

Loans Held for Investment, Net - Schedule of Company’s Loans Held for Investment (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans held for investment	$ 4,913,374
Allowance for credit losses	(665,142)
Loans held for investment, net	665,142	$ 0
Loans Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans held for investment, net	4,248,232
Current
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans held for investment	4,770,333
30-59 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans held for investment	66,839
60-89 days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans held for investment	46,173
> 90 days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans held for investment	$ 30,029

Loans Held for Investment, Ne_3

Loans Held for Investment, Net - Schedule of Allowance for Credit Losses on Loans Held for Investment (Details)	9 Months Ended
	Sep. 30, 2024 USD ($)
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance at January 1, 2024	$ 0
Balance acquired from Credova Merger	1,130,515
Charge-offs	(1,015,358)
Provision for credit losses	549,985
Balance at September 30, 2024	$ 665,142

Revolving Line of Credit (Detai

Revolving Line of Credit (Details) - USD ($) $ in Millions		9 Months Ended
	Jul. 01, 2024	Sep. 30, 2024
Line of Credit Facility [Line Items]
Percentage of borrowing	89%
Advance aggregate outstanding value		$ 1
Advance aggregate outstanding percentage		100%
Revolving Credit Facility
Line of Credit Facility [Line Items]
Revolving loan		$ 10
Bears interest rate	14.50%	15%
Advances outstanding revolving loan		$ 3.1

Convertible Promissory Notes -

Convertible Promissory Notes - Narrative (Details)			3 Months Ended	6 Months Ended	9 Months Ended
	Mar. 13, 2024 USD ($)	Jul. 19, 2023 USD ($)	Sep. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) day	Sep. 30, 2023 USD ($)
Convertible Promissory Notes [Line Items]
Conversion price					4.63641
Notes payable					$ 8,400,000
Percentage of purchase agreement for Private placement convertible note	9.75%
Convertible promissory notes				$ 22,500,000	$ 0	$ 22,500,000
Conversion of stock			$ 37,071,109
Promissory Note
Convertible Promissory Notes [Line Items]
Accrued interest					9.75%
Maturity dates					10 years
First Anniversary
Convertible Promissory Notes [Line Items]
Percentage of outstanding principal amount					120%
Second Anniversary
Convertible Promissory Notes [Line Items]
Percentage of outstanding principal amount					105%
Convertible Promissory Note
Convertible Promissory Notes [Line Items]
Accrued interest				5%
Convertible Senior Notes Due 2025 | Convertible Promissory Note
Convertible Promissory Notes [Line Items]
Conversion price percentage					140%
Debt instrument, consecutive trading days | day					10
Debt instrument, trading days | day					20
Board Members
Convertible Promissory Notes [Line Items]
Convertible notes payable	$ 10,000,000
Common Stock
Convertible Promissory Notes [Line Items]
Conversion of stock		$ 100,000,000

Convertible Promissory Notes _2

Convertible Promissory Notes - Schedule of Change in the Fair Value of the Notes Measured with Level 3 Inputs (Details) - USD ($)	3 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value as of beginning	$ 37,071,109	$ 3,197,905	$ 0
Principal balance of convertible notes issued	37,294,023	20,450,000	2,050,000
Change in valuation inputs or other assumptions		13,423,204	1,147,905
Conversion of convertible notes	(37,071,109)
Fair value as of ending	$ 0	$ 37,071,109	$ 3,197,905

Convertible Promissory Notes _3

Convertible Promissory Notes - Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs (Details) - $ / shares		9 Months Ended
	Jul. 19, 2023	Sep. 30, 2024
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Exercise Price	$ 9.08
Risk-Free Rate	4.60%
Maturity (in years)	4 years 9 months 18 days
Volatility	40%
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Exercise Price		$ 0
Risk-Free Rate		4.10%
Maturity (in years)		1 year 9 months 18 days
Volatility		75%

Leases - Narrative (Details)

Leases - Narrative (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2024 USD ($) contract	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) contract	Sep. 30, 2023 USD ($)
Lessee, Lease, Description [Line Items]
Number of lease contracts | contract	3		3
Real estate taxes	$ 100,000	$ 100,000	$ 400,000	$ 200,000
Florida
Lessee, Lease, Description [Line Items]
Lease escalating payments			$ 16,457
Incremental borrowing rate			10.50%
Montana
Lessee, Lease, Description [Line Items]
Incremental borrowing rate			9.75%
Operating lease, renewal term	5 years		5 years

Leases - Schedule of Operating

Leases - Schedule of Operating Lease and Other Supplemental Information (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Leases [Abstract]
ROU assets	$ 350,782	$ 324,238
Lease liabilities:
Current lease liabilities	167,749	310,911
Non-current lease liabilities	191,502	16,457
Total lease liabilities	$ 359,251	$ 327,368
Other supplemental information:
Weighted average remaining lease term	2 years 4 months 24 days	1 year
Weighted average discount rate	10%	10.50%

Leases - Schedule of Lease Paym

Leases - Schedule of Lease Payments Relating to the Company’s Operating Leases (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Leases [Abstract]
Remainder of 2024	$ 80,775
2025	144,273
2026	131,196
2027	44,112
Total lease payments	400,356
Less: imputed interest	(41,105)
Present value of operating lease liabilities	$ 359,251	$ 327,368

Warrant Liabilities (Details)

Warrant Liabilities (Details) - $ / shares	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Class of Warrant or Right [Line Items]
Warrant exercise price (in dollars per share)	$ 0.01
Warrants become exercisable and ending business days	30 days
Prior written notice of redemption	30 days
Public Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)	5,750,000
Stock price trigger for redemption of public warrants (in dollars per share)	$ 18
Threshold trading days for redemption of public warrants	20 days
Number of consecutive trading days	30 days
Warrants become exercisable and ending business days	3 days
Private Placement
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)		5,700,000
Common Stock
Class of Warrant or Right [Line Items]
Number of shares purchased (in shares)	1
Warrant exercise price (in dollars per share)	$ 11.50
Public Warrants
Class of Warrant or Right [Line Items]
Number of shares purchased (in shares)	1
Warrant exercise price (in dollars per share)	$ 11.50

Related Parties (Details)

Related Parties (Details) - USD ($)

1 Months Ended

3 Months Ended

9 Months Ended

Nov. 01, 2024

May 03, 2024

Feb. 27, 2024

Feb. 26, 2024

Jan. 31, 2024

Nov. 29, 2023

Aug. 25, 2023

Aug. 31, 2024

Apr. 30, 2024

Mar. 31, 2024

Aug. 31, 2023

Jun. 30, 2023

Sep. 30, 2024

Jun. 30, 2024

Mar. 31, 2024

Sep. 30, 2024

Jan. 01, 2024

Dec. 31, 2023

Related Party Transaction [Line Items]

Issuance of shares for consulting arrangement

$ 887,409

Restricted Stock Units (RSUs)

Related Party Transaction [Line Items]

Number of vested shares RSU's (in shares)

609,336

642,204

638,629

Granted RSU's (in shares)

150,000

490,140

2,276,710

Related Party

Related Party Transaction [Line Items]

Fixed fees

$ 80,000

$ 60,000

$ 80,000

Paid relating to agreement

$ 30,000

$ 172,000

Percentage of consideration paid for acquisition

1.50%

Expensed relating to agreement

$ 45,000

$ 187,000

Related Party | Restricted Stock Units (RSUs)

Related Party Transaction [Line Items]

Number of vested shares RSU's (in shares)

60,000

Granted RSU's (in shares)

120,000

Related Party | Convertible Promissory Note

Related Party Transaction [Line Items]

Maturity dates

10 years

Convertible note amount

$ 10,000,000

Board Members

Related Party Transaction [Line Items]

Convertible notes payable

$ 10,000,000

$ 10,000,000

Chief Operating Officer

Related Party Transaction [Line Items]

Severance costs, annual base salary, period

12 months

Severance costs, health insurance, period

12 months

Chief Operating Officer | Class A Common Stock

Related Party Transaction [Line Items]

Forfeiture (in shares)

1,704,223

Purchase Agreement | Related Party | Private Placement

Related Party Transaction [Line Items]

Maturity dates

10 years

Convertible note percentage

9.75%

9.75%

Letter Agreement | Related Party

Related Party Transaction [Line Items]

Related party transaction, agreement term

12 months

Paid relating to agreement

900,000

Credova Merger Agreement | Related Party

Related Party Transaction [Line Items]

Related party transaction, agreement term

12 months

Closing acquisition

$ 150,000

Credova Merger Agreement | Related Party | Class A Common Stock

Related Party Transaction [Line Items]

Issuance of shares for consulting arrangement (in shares)

183,349

Issuance of shares for consulting arrangement

$ 887,809

EveryLife Consulting Agreement | Related Party

Related Party Transaction [Line Items]

Received amount

$ 10,000

EveryLife Consulting Agreement | Related Party | Restricted Stock Units (RSUs)

Related Party Transaction [Line Items]

Number of vested shares RSU's (in shares)

60,000

30,000

40,000

EveryLife Consulting Agreement | Related Party | Restricted Stock Units (RSUs) | Subsequent Event

Related Party Transaction [Line Items]

Number of vested shares RSU's (in shares)

30,000

C6 Consulting Agreement | Related Party

Related Party Transaction [Line Items]

Reduce monthly fee

$ 15,000

$ 30,000

C6 Consulting Agreement | Board Members

Related Party Transaction [Line Items]

Received amount

$ 30,000

Strategic Consulting Agreement | Related Party

Related Party Transaction [Line Items]

Related party transaction, agreement term

1 year

Share Based Compensation - Narr

Share Based Compensation - Narrative (Details) - USD ($)		3 Months Ended				9 Months Ended		12 Months Ended
	Jan. 01, 2024	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unrecognized compensation cost related to grant of RSUs		$ (485,904)	$ 0
Weighted average remaining vesting period						1 year 9 months 10 days
Share-based compensation expense		5,796,823		$ 2,095,889		$ 16,855,006	$ 2,095,889
Unrecognized compensation cost		13,100,000				$ 13,100,000
2023 Employee Stock Purchase plan
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding percentage	1%
RSUs
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Issued RSUs (in shares)						5,023,858		2,354,989
Unrecognized compensation cost related to grant of RSUs						$ 19,200,000
Earnout Shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based compensation expense		$ 900,000		$ 800,000		$ 2,700,000	$ 800,000
Class A Common Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding percentage						5%
Common stock, par value (in dollars per share)		$ 0.0001				$ 0.0001		$ 0.0001
Class A Common Stock | 2023 Stock incentive plan
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding percentage						15%
Class A Common Stock | 2023 Employee Stock Purchase plan
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of stock issued (in shares)						600,000
Common Stock | 2023 Employee Stock Purchase plan
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock, par value (in dollars per share)	$ 0.0001
Common Stock | 2023 Employee Stock Purchase plan
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of stock issued (in shares)	425,000
Common Stock | Class A Common Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of stock issued (in shares)					1,447,523
Issued RSUs (in shares)		1,273,767	663,500
Unrecognized compensation cost related to grant of RSUs		$ 128	$ 66

Share Based Compensation - Sche

Share Based Compensation - Schedule of Activity with Respect to, and Status of, RSUs (Details) - Restricted Stock Units (RSUs) - $ / shares	3 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024
Number of RSUs
Balance at beginning of period (in shares)	3,028,559	3,185,623	1,655,542
Granted RSU's (in shares)	150,000	490,140	2,276,710
Forfeited RSU's (in shares)	(133,981)	(5,000)	(108,000)
Vested RSU's (in shares)	(609,336)	(642,204)	(638,629)
Balance at end of period (in shares)	2,435,242	3,028,559	3,185,623
Weighted Average Grant Date Value
Balance at beginning of period (in dollars per share)	$ 6.65	$ 8.93	$ 9.61
Granted (in dollars per share)	2.71	3.48	8.10
Forfeited (in dollars per share)	7.01	10.12	10.12
Vested (in dollars per share)	6.02	6.44	6.91
Balance at end of period (in dollars per share)	$ 6.64	$ 6.65	$ 8.93

Share Based Compensation - Sc_2

Share Based Compensation - Schedule of Common Stock and Current Interest Rates (Details)	Jul. 19, 2023 $ / shares
Share-Based Payment Arrangement [Abstract]
PSQH Stock Price (in dollars per share)	$ 9.08
Volatility	40%
Risk free rate of return	4.60%
Expected term (in years)	4 years 9 months 18 days

Share Based Compensation - Sc_3

Share Based Compensation - Schedule of Share-Based Compensation Expense (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based compensation expense	$ 5,796,823	$ 2,095,889	$ 16,855,006	$ 2,095,889
Cost of sales
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based compensation expense	28,407	2,239	108,392	2,239
General and administrative expenses
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based compensation expense	4,092,365	587,717	9,948,361	587,717
Research and development
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based compensation expense	411,470	201,810	1,149,456	201,810
Sales and marketing
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based compensation expense	1,264,581	393,323	4,761,388	393,323
Transaction costs incurred in connection with Credova Merger
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based compensation expense	$ 0	$ 910,800	$ 887,409	$ 910,800

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Assets and Liabilities Subject to Fair Value Measurements (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Assets
Cash and cash equivalents - Money market	$ 2,523,424	$ 10,301,371
Liabilities
Warrant liabilities	2,632,500	10,130,000
Earn-out liabilities	150,000	660,000
Total liabilities	2,782,500	10,790,000
Public Warrants
Liabilities
Warrant liabilities	1,207,500	4,715,000
Private Placement Warrants
Liabilities
Warrant liabilities	1,425,000	5,415,000
Level 1
Assets
Cash and cash equivalents - Money market	2,523,424	10,301,371
Liabilities
Earn-out liabilities	0	0
Total liabilities	1,207,500	4,715,000
Level 1 | Public Warrants
Liabilities
Warrant liabilities	1,207,500	4,715,000
Level 1 | Private Placement Warrants
Liabilities
Warrant liabilities	0	0
Level 2
Assets
Cash and cash equivalents - Money market	0	0
Liabilities
Earn-out liabilities	0	0
Total liabilities	0	0
Level 2 | Public Warrants
Liabilities
Warrant liabilities	0	0
Level 2 | Private Placement Warrants
Liabilities
Warrant liabilities	0	0
Level 3
Assets
Cash and cash equivalents - Money market	0	0
Liabilities
Earn-out liabilities	150,000	660,000
Total liabilities	1,575,000	6,075,000
Level 3 | Public Warrants
Liabilities
Warrant liabilities	0	0
Level 3 | Private Placement Warrants
Liabilities
Warrant liabilities	$ 1,425,000	$ 5,415,000

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Changes in Fair Value of the Public and Private Placements Warrants (Details) - USD ($)	3 Months Ended			9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value as of beginning				$ 0
Fair value as of ending				0
Private Placements Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value as of beginning	$ 2,565,000	$ 4,161,000	$ 5,415,000	0
Assumed in the Business Combination				4,389,000
Change in fair value	(1,140,000)	(1,596,000)	(1,254,000)	4,218,000
Fair value as of ending	1,425,000	2,565,000	4,161,000	8,607,000
Earn-Out Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value as of beginning	320,000	540,000	660,000	0
Assumed in the Business Combination				2,400,000
Change in fair value	(170,000)	(220,000)	(120,000)	(450,000)
Fair value as of ending	$ 150,000	$ 320,000	$ 540,000	$ 1,950,000

Segments - Schedule of Revenues

Segments - Schedule of Revenues, Net (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues, net:
Total revenues, net	$ 6,540,112	$ 2,030,900	$ 15,991,229	$ 2,938,641
Marketplace
Revenues, net:
Total revenues, net	717,692	875,546	2,389,801	1,783,287
Brands
Revenues, net:
Total revenues, net	2,615,012	1,155,354	7,048,995	1,155,354
Brands | Product sales
Revenues, net:
Total revenues, net	2,824,540	1,387,951	7,653,505	1,387,951
Brands | Other sales
Revenues, net:
Total revenues, net	18,789	0	37,527	0
Brands | Returns and discounts
Revenues, net:
Total revenues, net	(228,317)	(232,597)	(642,037)	(232,597)
Financial Technology
Revenues, net:
Total revenues, net	3,207,408	0	6,552,433	0
Financial Technology | Direct revenue
Revenues, net:
Total revenues, net	1,150,951	0	2,272,818	0
Financial Technology | Interest income on loans
Revenues, net:
Total revenues, net	749,199	0	1,850,115	0
Financial Technology | Loan and lease contracts sold, net
Revenues, net:
Total revenues, net	$ 1,307,258	$ 0	$ 2,429,500	$ 0

Segments - Schedule of Segment'

Segments - Schedule of Segment's Adjusted EBITDA (Details) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Revenues, net	$ 6,540,112			$ 2,030,900			$ 15,991,229	$ 2,938,641
Segment cost of revenues	(609,270)			(569,502)			(1,738,729)	(1,189,440)
Segment cost of goods sold	(1,771,109)			(903,672)			(4,601,360)	(903,672)
Segment gross profit	4,159,733			557,726			9,651,140	845,529
Segment operating costs	(8,576,720)			(4,508,222)			(20,879,961)	(8,082,601)
Adjusted EBITDA	(4,416,987)			(3,950,496)			(11,228,821)	(7,237,072)
Corporate operating expenses	(3,503,643)			(3,774,266)			(11,937,517)	(8,230,417)
Transaction costs incurred in connection with acquisitions	0			(3,309,597)			(2,295,502)	(7,048,177)
Share-based compensation (exclusive of what is included in transaction costs above)	(5,796,823)			(1,185,089)			(15,967,598)	(1,185,089)
Depreciation and amortization	(975,090)			(759,745)			(2,202,561)	(2,004,319)
Other (expense) income, net	(45,683)			119,957			110,295	173,644
Change in fair value of convertible notes	0			0			0	(14,571,109)
Change in fair value of earn-out liabilities	170,000			450,000			510,000	450,000
Change in fair value of warrant liabilities	2,175,000			(7,783,000)			7,497,500	(7,783,000)
Interest expense, net	(756,760)			(46,690)			(1,434,241)	(210,545)
Income tax benefit (expense)	12,437			262			(1,181)	(1,527)
Net loss	(13,137,549)	$ (11,235,246)	$ (12,576,831)	(20,238,664)	$ (20,721,307)	$ (6,687,640)	(36,949,626)	(47,647,611)
Marketplace
Segment Reporting Information [Line Items]
Revenues, net	717,692			875,546			2,389,801	1,783,287
Segment cost of revenues	(582,614)			(569,493)			(1,635,237)	(1,189,431)
Segment cost of goods sold	0			0			0	0
Segment gross profit	135,078			306,053			754,564	593,856
Segment operating costs	(3,701,865)			(2,871,552)			(9,807,606)	(6,445,931)
Adjusted EBITDA	(3,566,787)			(2,565,499)			(9,053,042)	(5,852,075)
Brands
Segment Reporting Information [Line Items]
Revenues, net	2,615,012			1,155,354			7,048,995	1,155,354
Segment cost of revenues	(4,358)			(9)			(4,358)	(9)
Segment cost of goods sold	(1,771,109)			(903,672)			(4,601,360)	(903,672)
Segment gross profit	839,545			251,673			2,443,277	251,673
Segment operating costs	(1,457,446)			(1,636,670)			(4,079,486)	(1,636,670)
Adjusted EBITDA	(617,901)			(1,384,997)			(1,636,209)	(1,384,997)
Financial Technology
Segment Reporting Information [Line Items]
Revenues, net	3,207,408			0			6,552,433	0
Segment cost of revenues	(22,298)			0			(99,134)	0
Segment cost of goods sold	0			0			0	0
Segment gross profit	3,185,110			0			6,453,299	0
Segment operating costs	(3,417,409)			0			(6,992,869)	0
Adjusted EBITDA	$ (232,299)			$ 0			$ (539,570)	$ 0

Commitments and Contingencies (

Commitments and Contingencies (Details) - Advertising Agreement $ in Millions	1 Months Ended
	Jun. 30, 2024 USD ($) installment	Oct. 31, 2023 USD ($) installment	Sep. 30, 2024 USD ($) installment
Commitments and Contingencies [Line Items]
Advertising commitment, term	1 year	1 year
Payment for advertising commitment	$ 0.8	$ 1
Number of installments | installment	12	6
Six Equal Installments
Commitments and Contingencies [Line Items]
Payment for advertising commitment		$ 0.2
Five Installments
Commitments and Contingencies [Line Items]
Payment for advertising commitment			$ 0.8
Number of installments | installment			5
Twelve Equal Installments
Commitments and Contingencies [Line Items]
Payment for advertising commitment	$ 0.1
Three Installments
Commitments and Contingencies [Line Items]
Payment for advertising commitment			$ 0.2
Number of installments | installment			3

Subsequent Events (Details)

Subsequent Events (Details)						1 Months Ended
	Oct. 31, 2024 USD ($)	Oct. 24, 2024 USD ($) investor $ / shares	Oct. 22, 2024 USD ($)	Oct. 16, 2024 USD ($)	Oct. 15, 2024 USD ($)	Oct. 31, 2024	Oct. 06, 2024 USD ($)	Sep. 30, 2024 USD ($)
Subsequent Event [Line Items]
Contract with customer liability								$ 300,000
Prepaid expense								$ 1,200,000
Subsequent Event
Subsequent Event [Line Items]
Prepaid expense, cancelled, amount returned							$ 900,000
Prepaid expense, cancelled, percent returned							72%
Number of positions eliminated, period percent			35%			35%
Common stock sold, aggregate purchase price		$ 5,350,000
Price per share (in dollars per share) | $ / shares		$ 2.70
Number of investors | investor		3
Subsequent Event | Class A Common Stock | Common Stock
Subsequent Event [Line Items]
Related party transaction, average closing price period		14 days
Related party transaction, closing PIPE purchase agreement, period		12 months
Subsequent Event | Employee Severance
Subsequent Event [Line Items]
Restructuring and related cost, expected cost			$ 400,000
Subsequent Event | Employee Severance, One Month of Health Insurance
Subsequent Event [Line Items]
Restructuring and related cost, expected cost			$ 37,000
Subsequent Event | C6 Consulting Agreement | Related Party
Subsequent Event [Line Items]
Related party transaction, monthly fees				$ 0	$ 15,000
Subsequent Event | Strategic Consulting Agreement | Related Party
Subsequent Event [Line Items]
Related party transaction, monthly fees	$ 60,000
Related party transaction, termination notice period	30 days